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ABSTRACT
TING-HUEI CHEN: Penalized Estimation Methods and Their Applications in
Genomics and Beyond
(Under the direction of Wei Sun and Jason P. Fine)
Various forms of penalty functions have been developed for regularized estima-
tion. The tuning parameter(s) of a penalty function play a key role in penalizing
all the noise to be zero and obtaining unbiased estimation of the true signals. For
penalty functions with more than one tuning parameters, previous studies have not
emphasized on the joint effect of all the tuning parameters. In the first topic, we
conduct a theoretical analysis to relate the ranges of tuning parameters of penalty
functions with the dimensionality of the problem and the minimum effect size. We
exemplify our theoretical results in several well-known penalty functions. The results
suggest that a class of penalty functions that bridges L0 and L1 penalties require less
restrictive conditions for variable selection consistency. The simulation analysis and
real data analysis support these theoretical results.
For the second topic, we consider the problem of identifying genomic features to
predict cancer drug sensitivity. Several drugs that share a molecular target may also
have some common predictive features. Therefore, it is desirable to analyze these
drugs as a group to identify the associated genomic features. Motivated by this prob-
lem, we develop a new method for high-dimensional feature selection using a group of
responses that may share a common set of predictors in addition to their individual
predictors. Simulation results show that our method has better performances than
existing methods. Between-study validation in real data shows that the genomic fea-
iii
tures selected for a drug target can form good predictors for other drugs designed for
the same target.
For the third topic, we address an estimation problem where certain parameter
values such as 0 would cause an identifiability issue. In the maximum likelihood
estimation framework, due to the issue of the unidentifiable parameter, the maximum
likelihood estimator have regular properties only if the likelihood function is specified
correctly with respect to the parameter values. We propose a penalized estimation
procedure using the adaptive Lasso penalty to address the potential identifiability
issue. We study the asymptotic property of the proposed estimator and evaluate our
method in extensive simulations and real data analysis.
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CHAPTER 1: Introduction
1.1 The role of tuning parameters of penalty functions
Variable selection has been well studied in the classical setting of fixed dimen-
sional covariates, with numerous penalization methods shown to yield sparse oracle
estimation. Asymptotically, such procedures guarantee that the zero coefficients are
estimated to be zero exactly and the non-zero coefficients are efficiently estimated
with variance equal to that with known zero coefficients. Extending such methods
to high dimensional covariates is technically challenging. Valid estimation is only
possible if the regression model is sufficiently sparse, that is, a high percentage of
covariates have no effect, with the number of non-zero effects growing at some rate
that depends on the sample size.
Several penalty functions have been proposed for regularized estimation in such
high dimensional setting. One of the most popular penalty functions is the Lasso
penalty [Tibshirani, 1996]. Lasso is a convex penalty, so that including this penalty
in the objective function (e.g., adding it to residual sum squares or subtracting it from
log likelihood) does not change the convexity (e.g., residual sum squares) or concavity
(e.g., log likelihood of generalized linear model) of the objective function. Therefore,
it is computationally efficient to solve the penalization problem because finding the
global minimum/maximum is equivalent to finding the local minimum/maximum.
Recently, several groups have studied the theoretical properties of Lasso for fixed
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p [Zou, 2006] or for high-dimensional regression problems [Zhao and Yu, 2006; Mein-
shausen and Bu¨hlmann, 2006; Zhang and Huang, 2008]. One important finding of
these studies is that the variable selection consistency of Lasso requires the irrep-
resentable condition on the design matrix [Zhao and Yu, 2006], or equivalently, the
neighborhood stability condition [Meinshausen and Bu¨hlmann, 2006]. Intuitively,
this condition requires that the covariates not in the true model (which are referred
to as “unimportant covariates” hereafter) cannot be represented by the covariates be-
longing to the true model (which are referred to as “important covariates” hereafter).
This condition is often not satisfied at high dimensionality such as NP dimensionality,
i.e. the dimensionality of nonpolynomial (NP) order of sample size. For example, in
GWAS, an important covariant, which is a SNP associated with the disease status, is
often correlated with several nearby SNPs that are unimportant. In other words, the
SNP-to-SNP correlations are totally due to linkage disequilibrium and have nothing
to do with disease association.
In a pioneering work, Fan and Li [2001] have build a theoretical framework for non-
concave penalized likelihood for variable selection, and advertised a folded-concave
penalty, the Smoothly Clipped Absolute Deviation Penalty (SCAD) proposed by Fan
[1997], which is defined by
p′SCAD(|βj|) = {λI(|βj| ≤ λ) + [(aλ− |βj|)/(a− 1)]I(λ < |βj| < aλ)} ,
where λ > 0 and a > 2 are two regularization parameters. SCAD employs Lasso
penalty for signals smaller than a threshold λ, then reduces the penalty increase rate
for stronger signals, and finally the penalty becomes a constant for signals larger
than aλ. This reduction of penalty for stronger signals effectively removes the bias
of Lasso for strong signals.
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Another penalty, the Minimax Concave Penalty (MCP) [Zhang, 2010], is defined
by
p′MCP(|βj|) = I(|βj| < aλ)(aλ− |βj|)/a,
where λ > 0 and a > 0 are two regularization parameters. MCP increases with a rate
of λ from effect size zero, i.e., lim|βj |→0+ p
′
MCP(|βj|)→ λ. Then it immediately reduces
the penalty increase rate. The penalty becomes constant for effect size larger than
aλ. MCP converges to L0 penalty when a→ 0, and it converges to L1 penalty when
a→∞.
Another folded-concave penalty, the Smooth Integration of Counting and Absolute
deviation penalty (SICA) [Lv and Fan, 2009] is a linear combination of L0 and L1
penalties:
pSICA(|βj|) = λ
[ |βj|
|βj|+ τ I(|βj| 6= 0) +
τ
|βj|+ τ |βj|
]
,
where λ > 0 and τ > 0 are two regularization parameters. A more general class of
linear combination of L0 and L1 penalties has been studied by Liu and Wu [2007].
The Log penalty [Friedman, 2008; Sun et al., 2010] is defined by
plog(|βj|) = λ log(|βj|+ τ),
where λ > 0 and τ > 0 are two tuning parameters. As mentioned by Friedman
[2008], Log penalty bridges L0 and L1 penalties. Specifically, it converges to L0 or
L1 penalties if τ → 0 or τ → ∞, respectively. Lv and Fan [2009] pointed out the
Log penalty is closely related with the SICA penalty. Sun et al. [2010] suggested
the Log penalty can be viewed as iterative adaptive Lasso and provides a Bayesian
interpretation of the Log penalty.
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Another class of folded-concave penalty is the bridge penalty pBridge(|βj|) = |βj|a,
where 0 < a < 1. Friedman [2008] has shown that the bridge penalty spans a similar
spectrum as Log penalty, and the latter has smaller discontinuities, hence more stable
coefficient estimates. In addition, lim|βj |→0+ p
′
Bridge(|βj|) → ∞, which leads to extra
computational challenge for implementation. Therefore we do not include the bridge
penalty for the latter theoretical studies.
It has been established, in both finite dimensions and diverging dimensions where
p = O(na) or p = O(exp(na)) (a > 0) that penalization methods based on folded-
concave penalties provide consistent estimates without requiring the irrepresentabil-
ity condition [Fan and Lv, 2010]. In addition, Mazumder et al. [2011] have studied
properties of Log, SCAD and MCP in the optimization using a coordinate-descent
approach.
The performances of the variable selection rely on the proper selection of regu-
larization parameters $. All of these four penalties (SCAD, MCP, SICA and Log)
have two regularization parameters. In practice, immediate questions concerning
these regularization parameters are whether they both should be tuned, and what
is the consequence to tune only one of them in order to improve computational ef-
ficiency? Previous works have provided recommendations regarding to the choice of
tuning parameters, but there is no systematic asymptotic studies on the roles of mul-
tiple tuning parameters. This motivates us to asymptotically study the relation of
the choice of tuning parameters with the difficulty of the variable selection problem,
namely the minimum effect size and the dimensions (both the number of important
and unimportant covariates).
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We will study the role of tuning parameters of penalty functions by evaluating
if they could satisfy the conditions of weak oracle properties. Weak oracle prop-
erty of penalized likelihood method in NP dimensionality (i.e., the dimensionality of
nonpolynomial order of sample size) was introduced by Lv and Fan [2009] for pe-
nalized least squares, and was extended to generalized linear regression by [Fan and
Lv, 2011]. An estimator βˆ = (βˆT1 , βˆ
T
2 )
T is considered to have weak oracle property if
βˆ2 = 0 with probability tending to 1 as n→∞, and consistency for βˆ1 under L∞ loss.
However, the conditions of weak oracle properties in Fan and Lv [2011] are mainly
imposed on a single tuning parameter of penalty functions, and it is unclear the role
of multiple tuning parameters. Therefore, we propose to generalize the theorems of
weak oracle properties in Fan and Lv [2011]. This modification is necessary to allow
more penalties to be studied for their tuning parameters.
1.2 Prediction of cancer drugs’ sensitivities
Cancer drugs development has shifted from traditional one-size-fits-all cytotoxic
chemotherapy to molecularly targeted cancer drug therapy. The cytotoxic chemother-
apy drugs target the signaling pathway for cell division. Although cancer cells have
out of control of growth pattern, normal cells such as cells in the bone marrow and
hair follicles also divide regularly. The chemotherapy drugs cannot distinguish cancer
cells from normal ones so that its side-effects can be severe. Unlike chemotherapy
drugs, molecularly targeted cancer drugs aim to exploit the specific vulnerability of
cancer cells. With advances in biotechnology, the studies of genomics and proteomics
have generated huge amount of molecular data for targeted cancer drugs development.
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Hoelder et al. [2012] gives a review about the targeted cancer drugs development.
For instances, several drugs have been approved by FDA to target mutational activa-
tion of BCR-ABL tyrosine kinase in chronic myeloid leukemia, EGFR tyrosine kinase
in non-small cell lung cancer, BRAF kinase in melanoma, and HER2 amplification
in breast cancer [Yap and Workman, 2012].
Despite the effectiveness of these drugs in many patients, not all the patients
who have a targeted mutation response to the corresponding drug, which is partly
due to the (genome-wide) genetic heterogeneity among cancer patients. For example,
only 30% patients with HER2 amplification and 50% patients with BRAF muta-
tion respond to the corresponding drugs [De Palma and Hanahan, 2012]. Therefore,
statistical models that can predict drug sensitivities from patient-specific genomic
data will be of great value for cancer treatment. Such genomic data may include
DNA alterations, gene expression, and epigenetic marks. Owing to the advance of
high-throughput array/sequencing techniques, these genomic data can be collected
in routine clinical practice in the near future [Yap and Workman, 2012]. Robust
preclinical model systems such as cancer cell lines that reflect the genomic diversity
of human cancers can be used to build such predictive model [Caponigro and Sellers,
2011].
Recently, two groups have studied drug sensitivities in a large number of cancer
cell lines [Garnett et al., 2012; Barretina et al., 2012]. In a panel of several hundred
human cancer cell lines, Garnett et al. [2012] measured the sensitivities of 130 drugs,
mutation statuses of 64 commonly mutated cancer genes, and genome-wide copy
number alterations and gene expression. In a panel of 479 cancer cell lines, Barretina
et al. [2012] have screened 24 anticancer drugs and measured the mutation statuses
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of 1600 genes, as well as genome-wide copy number alterations and gene expression.
Both studies conducted univariate drug-by-drug analysis to select genomic features
associated with drug sensitivity as measured by the half-maximal inhibitory concen-
tration (IC50), i.e., the amount of drugs to kill 50% of the cancer cells. Since drugs
can be grouped by their targets such as a gene product or a signaling pathway, jointly
analysis of the drugs sharing a target may improve the power to identify common
genomic features.
Regarding feature selection for multivariate responses, two types of methods have
been applied: group-wise selection and bi-level selection. Group-wise variable selec-
tion methods, such as group Lasso [Yuan and Lin, 2006] or group adaptive Lasso
[Wang and Leng, 2008], assume all the response variables within a group are asso-
ciated with the same set of covariates [Huang et al., 2012]. The assumption that
all drugs sharing the same target (response variables within a group) have the same
associated genomic features is unrealistic. The analysis results of the studies (Gar-
nett et al. [2012] and Barretina et al. [2012]) show that in addition to some shared
features, drugs with the same target have their own individual features respectively.
In contrast, bi-level selection methods encourage the selection of covariates associ-
ated with all the response variables, but also allow some covariates to be associated
with one or a few response variables [Breheny and Huang, 2009] are more appropriate
for the application. A few methods have been developed for bi-level selection, such
as group bridge [Huang et al., 2009] and composite MCP [Breheny and Huang, 2009].
Suppose in a group of n samples, we observe q response variables, denoted by
yk = (y1k, ..., ynk)
T (1 ≤ k ≤ q), and p covariates, denoted by xj = (x1j, ..., xnj)T
(1 ≤ j ≤ p). In addition, let β denote the coefficients matrix with each row as
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bj = (βj1, ..., βjq) and each column as bk = (β1k, ..., βpk), and ‖‖1 to be the 1-norm.
The objective function of 1-norm group bridge is
1
2n
q∑
k=1
‖yk −Xbk‖22 + λ
p∑
j=1
cj‖bj‖γ1 , (1.2.1)
where λ > 0 is the tuning parameter, γ is the bridge index, and cj is constants.
Following [Huang et al., 2012], composite penalties are defined as:
ρO(
q∑
k=1
ρI(|βjk)|),
where ρO is an outer penalty applying to a some of inner penalties ρI . Composite
MCP is using both ρO and ρI to be the MCP penalty, which is presented in the
previous section.
Although these methods work satisfactorily in many real data analyses, we find
that their performances are limited in our preliminary simulation analysis for ge-
nomic applications where the genomic features have strong correlations. As shown
in our study results on the penalty functions in the previous section, their limited
performance may be due to the properties of incorporated penalty functions. These
issues motivate us to develop a new method to construct predictive models of cancer
drug sensitivities using genomic features.
Based on the study results of the first paper, the Log penalty has its advantages
in the high dimension and low sample size problem. In addition, the previous study
of penalized estimation with univariate response variable has shown that the method
incorporated with Log penalty has better performance than other existing penalty
functions including Lasso or elastic net [Sun et al., 2010]. Therefore, we propose to
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extend the univariate version of method in [Sun et al., 2010] for multivariate penal-
ized estimation.
The penalized estimation method in [Sun et al., 2010] is built based on the
Bayesian hierarchical model, which can be considered as Bayesian shrinkage estima-
tion. The principle is to assign priors with mean 0 on the parameters that are subject
for shrinkage. Consider a univariate linear regression problem with both response and
covariates being standardized, yi =
∑p
j=1 xijβj + ei, where e ∼ N(0n×1, σ2In×n) and
p is the number of covariates. In this case, the parameters which are subject for
shrinkage are the coefficients βj. One choice for the prior of βj is Normal distribution
with mean 0 and variance σ2j . The assigned priors on σ
2
j are key to the performance
of the Bayesian shrinkage methods. Several priors have been proposed for σ2j such as
inverse-Gamma or exponential prior, and the obtained Bayesian shrinkage methods
have been suggested as Bayesian Lasso [Yi and Xu, 2008].
The priors in [Sun et al., 2010] are set as
p(βj|κj) = 1
2κj
exp
(
−|βj|
κj
)
, (1.2.2)
p(κj|δ, τ) = inv-Gamma(κj; δ, τ) = τ
δ
Γ(δ)
κ−1−δj exp
(
− τ
κj
)
, (1.2.3)
where δ > 0 and τ > 0 are two hyperparameters. The Bayesian shrinkage method
constructed by the above priors has shown its advantages compared to other existing
methods [Sun et al., 2010].
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1.3 Models that are subject to unidentifiable parameters
The problem of statistical inference in the presence of nuisance parameters that
are not identified under the null hypothesis has been studied in several literatures. It
is a non-regular testing framework since the nuisance parameter only present under
the alternative hypothesis. Therefore, the standard large sample asymptotic theory
cannot be directly applicable (Davtes [1977], Davies [1987]). Andrews [1993] consid-
ers the tests of structural change with unknown change point, where the unknown
change point is not identifiable under the null hypothesis, and provides tests for var-
ious nonlinear models applied in econometric applications. Hansen [1996] studies the
asymptotic distribution theory for the tests of model that are subject to unidentifiable
parameters including the form of additive nonlinearity and allowing for stochastic re-
gressors and weak dependence.
For the estimation problems, there are extensive literatures on estimation of the
change point. For instance, Bai [1997] establishes the convergence rate and asymp-
totic distribution for the least square estimation of a change point in multiple regres-
sion. Muggeo [2003] considers the regression models with one or more break-points
parameters and utilizes a linearization technique for fitting piecewise terms in the
models. He and Severini [2010] studies the theoretical properties of maximum likeli-
hood estimators of the parameters of a multiple change-point model. They establish
the consistency, the convergence rate, and the asymptotic distribution of the maxi-
mum likelihood estimators.
In the maximum likelihood estimation framework, due to the unidentifiable pa-
rameter (ζ) issue under null hypothesis (β = 0), the maximum likelihood estimator
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(MLE) have regular properties only if the likelihood function is specified correctly
with respect to the parameter value of β. Specifically, when β = 0, the parameters
ζ and β should be both absent from the likelihood function; then the MLE for the
rest parameters are regular. On the contrary, when β 6= 0, the parameters ζ and
β are both present in the likelihood function; the MLE do not have identifiability
issues. Take the change point model estimation as an example. The parameter ζ is
the change point parameter, and it exists only when β 6= 0. Instead of estimating the
change points like the above methods, we are interested in designing an estimation
procedure that can automatically take care of the specification of correct likelihood
function with respect to the values of β without assuming the existence of change
points.
Since whether β equals to 0 plays a key role in determining the form of likeli-
hood function, we utilize the idea of penalization estimation procedure and apply
adaptive Lasso penalty to β. The adaptive Lasso penalty incorporated to β has the
form: λ|β|w, where λ is a tuning parameter, and w stands for the adaptive weight
associated to β. As shown in [Zou, 2006], given a proper chosen w, adaptive lasso
performs as well as if the true underlying likelihood were given in advance.
To choose a proper weight for β, we propose to apply the idea of constructing a test
statistics in (Davtes [1977]. They have established the weak asymptotic optimality
properties against local alternatives for their proposed test statistics, and its form of
critical region is:
{ sup
L≤ζ≤U
T (ζ) > c}, (1.3.1)
where T (ζ) is assumed to be an appropriate test statistic and the range of [L,U ] is
the possible values for ζ. For large values of supL≤ζ≤U T (ζ), the null hypothesis will
11
be rejected. Similarly, we take the supremum of profile likelihood estimates of βˆ(ζ)
over a range of possible values of ζ to be the weight for β to construct our estimation
procedure.
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CHAPTER 2: The role of tuning parameters
2.1 Introduction
In genome-wide association (GWA) studies, the goal is to identify the genetic
factors such as single nucleotide polymorphisms (SNPs) that are associated with dis-
eases. With the availability of a dense map of SNPs, it is statistically very challenging
to select the important SNPs from millions of SNPs using only a couple of thousand
samples. Regularized estimation procedures can be applied for simultaneous selec-
tion of important variables (SNPs) and estimation of their effects for high dimensional
data in GWA studies. The objective function of the regularized estimation is com-
posed of a model fitting metric (e.g., likelihood function) and a penalty function for
the parameters subject to regularization. Prior to the usage of regularized estimation,
screening can be applied to reduce the number of SNPs to be considered for penalized
estimation. However, due to the high correlation of neighboring SNPs, the number
of SNPs that pass a reasonable screening criterion is often larger than or much larger
than the sample size.
We use the real SNP genotype data from a recent study [Wright et al., 2014] to il-
lustrate the correlation structure of genotype data. We take the genotypes of 645,316
SNPs in chromosome 1 from 1,198 samples, and randomly pick 30 SNPs as important
variables to simulate the response under the linear model assumption. The effect size
is simulated as 0.7 and the residual errors are standard normal variables. Figure
4.1 shows a Manhattan plot of the marginal association p-values. The 30 important
SNPs are labeled by grey vertical lines. It is obvious that the high correlation among
13
nearby SNPs leads to small p-values for those SNPs that are close to the 30 impor-
tant SNPs. If we apply screening using the p-value cut-off 10−4, 3,087 SNPs will be
selected which include 20 of the 30 important SNPs. Alternatively, if the p-value
cut-off is 10−8, 991 SNPs will be selected, which include only 13 of the 30 important
SNPs. Thus screening method can be helpful to certain extend, and screening with
stringent threshold would lead to many false negatives. This conclusion is consistent
with the extensive empirical study by Bu¨hlmann and Mandozzi [2012]. Therefore,
the penalty function itself is still the key for high dimensional data analysis, and it
is desirable to identify penalty functions that can tolerate higher dimension.
Genomic Location
-L
og
10
(p
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Figure 2.1: Marginal association p-values for 645,316 SNPs on chromosome 1. The
grey vertical lines denote the positions of 30 important SNPs. The genomic location
spans 248,484,829 base-pairs. Note that a SNP is at a single base-pair location.
Several penalty functions have been proposed for high dimensional data analy-
sis. One of the most popular penalty functions is the Lasso penalty [Tibshirani,
1996]. The variable selection consistency of the Lasso requires the irrepresentable
condition [Zhao and Yu, 2006] that there is no strong correlation between the “im-
portant covariates” that have non-zero effects and the “unimportant covariates” that
have zero effects. This condition may not be satisfied in some applications, such as
GWAS studies. Recent studies have shown that a class of folded concave penalties
can achieve variable selection consistency without requiring such an irrepresentable
condition [Fan and Lv, 2010]. These folded concave penalties include, but are not
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limited to SCAD (Smoothly Clipped Absolute Deviation) [Fan, 1997; Fan and Li,
2001], MCP (Minimax Concave Penalty) [Zhang, 2010], SICA (Smooth Integration
of Counting and Absolute deviation) [Lv and Fan, 2009], and a Log penalty (Fried-
man [2008], Sun et al. [2010]).
A common concern in real data applications of penalized estimation is to tune the
regularization parameters to achieve the two fundamental goals of penalized estima-
tion: to penalize all the noise to be zero and to obtain an unbiased estimation of the
true signals. However, it may not be clear whether such “optimal” tuning is possible,
and this is the focus of our study. Moreover, all the aforementioned folded-concave
penalties have two tuning parameters, and thus in practice, the immediate questions
concern whether they both should be tuned, and what is the consequence of tuning
only one of them in order to improve computational efficiency. Previous work has
provided recommendations regarding the choice of tuning parameters, but there is no
systematic asymptotic study on the roles of multiple tuning parameters. To address
those issues, we will relate the choice of tuning parameters to the difficulty of the
variable selection problem, namely the minimum effect size and the dimensions, i.e.,
the number of important and unimportant covariates.
The results suggest that a class of penalty functions that bridges L0 and L1
penalties such as Log and SICA requires less restrictive conditions on dimensionality
and minimum effect sizes, while achieving the two fundamental goals of penalized
estimation. For the tuning of the regularization parameters, our study shows that
both SICA and Log penalties have very limited performance if only one of the two
regularization parameters is tuned, while tuning both regularization parameters can
significantly improve their performances, although at the price of heavier computa-
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tional burden. Our results are also insightful for designing other penalty functions.
For example, our results imply that two tuning parameters are sufficient to achieve
the two fundamental goals. Therefore, penalties with more than two regularization
parameters may not be needed due to the substantial increase of computational cost.
We conducted empirical analyses of the penalty functions using both simulated
data and real data in GWA settings. Those empirical results support the idea that the
class of penalty functions that bridges L0 and L1 hold promise for genomic studies.
2.2 Theoretical results
2.2.1 Notations and problem setup
Let p$(β) be a penalty function of β, where $ are regularization parameters with
arbitrary dimension. p$(β) is referred to as a folded concave penalty if it satisfies
the following condition:
Condition 1. p$(β) is concave in β ∈ [0,∞), with continuous derivative p′$(β) ≥ 0,
and p′$(0+) > 0.
We formulate the effects of the covariates via a generalized linear regression model,
permitting continuous and discrete outcome variables. Consider a sample of n re-
sponses, y = (y1, ..., yn)
T, where each yi, i = 1, ..., n, is independently generated from
an exponential family distribution with a density: p(yi|θi) = exp {[yiθi − b(θi)]/φ+ c(yi, φ)},
where θi is the canonical parameter and φ ∈ (0,∞) is the dispersion parameter. Let
xij be the value of the j-th covariate in the i-th sample, and let X = (xij) be a
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n × p matrix of the covariates’ values. We assume that X has been normalized
such that
∑n
i=1 x
2
ij = n, for j = 1, ..., p. Under the assumed generalized linear
model, θi =
∑p
j=1 xijβj, where βj’s are regression coefficients. Let E(y) = µ(θ) =
(∂θ1b(θ1), ..., ∂θnb(θn))
T and Σ(θ) = diag
{
∂2θ1b(θ1), ..., ∂
2
θn
b(θn)
}
. We maximize the pe-
nalized likelihood Qn(β) = ln(β)−
∑p
j=1 p$(|βj|), where ln(β) = n−1
[
yTθ − 1Tb(θ)]
is an affine transformation of the log-likelihood.
Without loss of generality, we assume that the first s covariates of X are impor-
tant (i.e., having non-zero effect on the response variable) and denote them collec-
tively by X1, and then denote the remaining p − s unimportant covariates by X2,
such that X = (X1, X2). Similarly, we partition β and θ = Xβ for the impor-
tant and unimportant covariates such that β = (βT1 , β
T
2 )
T and θ = (θT1 ,θ
T
2 )
T. Let
β0 = (β
T
01, β
T
02)
T = (β01, ..., β0p)
T be the true coefficients, such that β02 = 0. Let θ0
be the true values of θ such that θ0 = Xβ0.
It is difficult to analytically study the global maximizer of the penalized likelihood.
Following previous works [Fan and Lv, 2011], we study the local maximizer of the
penalized likelihood that satisfies the set of sufficient and almost necessary conditions
specified in Theorem 1 (see Appendix).
2.2.2 The role of the tuning parameters
The dimension of the regression problem and the minimum effect size are assumed
to satisfy the following conditions:
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Condition 2.1. log p = O(nα) and s = O(nν), respectively, with 0 ≤ α < 1 and
0 ≤ ν < 1/2.
Condition 2.2. dn ≡ 2−1 min1≤j≤s{|βj0|} = O(n−γ0(log n)1/2) for some γ0 ∈ (ν, 1/2).
The restriction of γ0 > ν (which is equivalent to s < n
γ0) in Condition 2.2 can
be understood as an identifiability condition so that dns = O(n
ν−γ0(log n)1/2) can be
bounded by a constant. Otherwise the response variable is unbounded, with non-
trivial probability.
A maximizer of the penalized likelihood, βˆ = (βˆT1 , βˆ
T
2 )
T, is considered to have
weak oracle property if βˆ2 = 0 with probability tending to 1 as n → ∞, and βˆ1
is consistent under L∞ loss [Lv and Fan, 2009]. We will study the role of tuning
parameters by studying the conditions for the weak oracle property. To this end, we
generalize the conditions for the weak oracle property in Fan and Lv [2011] to impose
constraints on the penalty function rather than particular tuning parameters, which
gives the following conditions 3.1-3.3. This generalization is necessary because the
original conditions are too stringent for any penalty function whose p′$(0+) involves
more than one tuning parameter. For example, the Log penalty cannot satisfy the
original conditions for the weak oracle property. After generalizing the conditions,
we can show that the Log penalty can indeed fulfills the conditions of the weak oracle
property.
Condition 3.1. p′$(dn)  b−1s dn, where bs ≡ O(nγs) = O(n‖[XT1 Σ(θ0)X1]−1‖∞) with
γs ≥ 0. A corollary of condition 3.1 is p′$(dn) dn.
18
Condition 3.2.
∥∥XT2 Σ(θ0)X1[XT1 Σ(θ0)X1]−1∥∥∞ ≤ min {Kp′$(0+)/p′$(dn), O(nν)} for
K ∈ (0, 1).
Condition 3.3. p′$(0+) max(n−2γ0+2ν log n, nν−1/2(log n)1/2) and p′$(0+) > ηpσ−1/2(1−
K)−1, where K is defined in condition 3.2, σ is a constant that is defined based on the
range of the response variable y (see proposition A1 in the Supplementary Materials
for details), and ηp = n
−1/2+α/2(log n)1/2.
Condition 3.1 requires the derivative of the penalty function (i.e., the increase
of penalization as the regression coefficient increases) for important covariates to be
small enough. Condition 3.2 says that the ratio of the penalties’ derivatives for unim-
portant covariates and for important ones (p′$(0+)/p
′
$(dn)) should be large enough
relative to the maximum correlation between important and unimportant covariates,
which is a generalization of the irrepresentable condition for Lasso [Zhao and Yu,
2006]. Condition 3.3 requires the derivative of the penalty function for unimportant
covariates to be large enough. In contrast to the conditions for the weak oracle prop-
erty in Fan and Lv [2011], a critical modification is that we restrict the size of p′$(0+)
in condition 3.3, which replaces the condition λn  n−α(log n)2 stated in equation
(18) of Fan and Lv [2011]. For SCAD and MCP, p′$(0+) = λn, and thus constraints
on λn or p
′
$(0+) are equivalent. However, for Log and SICA, p
′
$(0+) = O(λn/τn).
Therefore, the generalized condition only requires the ratio of the two regulariza-
tion parameters to be large enough instead of imposing a constraint on λn itself.
Given conditions 2.1-2.2, conditions 3.1-3.3, and conditions 4.1-4.4 (presented in the
Appendix), which are for the design matrix X, we have the weak oracle property
(Theorem 2 in the Appendix).
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One immediate conclusion from conditions 3.1-3.3 is that the constraints on the
penalty function p$(β) are applied on the two quantities p
′
$(0+) and p
′
$(dn). With
the appropriate design, two tuning parameters can give enough degrees of freedom
on these two quantities so that conditions 3.1-3.3 are satisfied.
Next we discuss the implications of conditions 3.1-3.3 for the four folded concave
penalties: SCAD, MCP, Log, and SICA. It is more convenient to define SCAD and
MCP by their derivatives.
p′SCAD(|βj|;λ, a) = {λI(|βj| ≤ λ) + [(aλ− |βj|)/(a− 1)]I(λ < |βj| < aλ)} ,
where λ > 0 and a > 2 are two regularization parameters.
p′MCP(|βj|;λ, a) = I(|βj| < aλ)(aλ− |βj|)/a,
where λ > 0 and a > 0 are two regularization parameters. The Log and SICA
penalties are defined as
plog;λ,τ (|βj|) = λ log(|βj|+ τ), and
pSICA(|βj|;λ, τ) = λ {I(|βj| 6= 0)|βj|/(|βj|+ τ) + τ |βj|/(|βj|+ τ)} ,
respectively, where λ > 0 and τ > 0 are two regularization parameters. In the fol-
lowing discussions, the tuning parameters employed by a penalty are indicated by
subscripts. For example, the SCAD penalty with one tuning parameter λn (the other
regularization parameter a being set as constant) is denoted by SCADλn and the
SCAD penalty with two tuning parameters λn and an is denoted by SCADλn,an .
Let ηp = n
−1/2+α/2(log n)1/2, which is a monotone transformation of dimension
log(p) = O(nα). Let ηd = min(n
γ0/2(log n)−1/4, n−γ0+1/2), which, by condition 2.2, is
20
a function of the minimum effect size: dn ≡ min1≤j≤s{|βj0|} = O(n−γ0(log n)1/2). In
the following propositions, we will discuss the properties of different penalties with
respect to s (the number of non-zero coefficients), dn, ηd, and ηp.
Proposition 1. [SCADλn , SCADλn,an , or MCPλn ] If dn  ηp and s  ηd, there
exist λn such that dn  λn > ηp to satisfy conditions 3.1-3.3 for the weak oracle
property. However, there is no such tuning parameter if dn  ηp.
Proposition 2. [MCPλn,an ] There are tuning parameters that satisfy conditions
3.1-3.3 for the weak oracle property without further constraints other than s nγ0 ,
as is specified in condition 2.2.
Proposition 3. [SICAλn or Logλn ] There are tuning parameters that satisfy con-
ditions 3.1-3.3 for the weak oracle property if dn  ηp, s ηd, and
∥∥XT2 Σ(θ0)X1(XT1 Σ(θ0)X1)−1∥∥∞ ≤ K (dn/τ + 1)2 ,
where K ∈ (0, 1) was defined in condition 3.3. There is no such tuning parameter if
dn  ηp.
Proposition 4. [SICAλn,τn or Logλn,τn ] There are tuning parameters that satisfy
conditions 3.1-3.3 for the weak oracle property without further constraints other than
s nγ0 , as is specified in condition 2.2.
Corollary 1. [Restriction on tuning parameter if dn  ηp] To satisfy condition
3.1-3.3 requires an → 0+ for MCPλn,an , and τn → 0+ for SICAλn,τn and Logλn,τn .
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The proofs of Propositions 1-4 and Corollary 1 are presented in the Supplemen-
tary Materials.
By Proposition 1, if dn  ηp or dn  ηp, SCAD has similar theoretical proper-
ties when one or two tuning parameters are used. This conclusion is consistent with
many previous works where SCAD has satisfactory performance when the regulariza-
tion parameter a is set to be a constant, e.g., 3.7. Using two tuning parameters (λn
and an) does have some advantage over one tuning parameter (λn) when dn = O(ηp).
However, since the situation of dn = O(ηp) only covers a negligible part of the space
for dn, we do not discuss it further here. Proposition 1 also states that if dn  ηp,
in other words, if the effect size is not large enough relative to the dimension, then
there is no tuning parameter of SCAD to satisfy conditions 3.1-3.3. Specifically, con-
dition 3.1 requires p′$(dn)  dn, and condition 3.3 requires p′$(0+) > cηp, where
c is a constant. These two conditions cannot both be satisfied if dn  ηp. Specif-
ically, if SCAD satisfies condition 3.3, then p′$(0+) = λn > cηp. Given dn  ηp
and ηp < λn/c, we have dn  λn, and then we can show that p′$(dn) = λn, which
contradicts condition 3.1. In addition, we can see that in this situation, both p′$(0+)
and p′$(dn) are functions of λn so that a plays no role in fulfilling conditions 3.1 and
3.3. On the other hand, tuning only one regularization parameter is a computational
advantage of SCAD.
By Propositions 1 and 2, tuning both λn and an significantly improves the per-
formance of MCP if dn  ηp. Specifically, if MCP satisfies condition 3.3, then
p′$(0+) = λn > cηp. Then given dn  ηp, we have dn  λn. However, given a
properly tuned an = o(1) such that dn ≥ anλn, we have p′$(dn) = 0, which allows
MCP to satisfy condition 3.1.
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By Proposition 3, if we set τ = O(1) and only tune the regularization parameter
λ, then SICAλn and Logλn require the following condition to achieve the weak oracle
property: ∥∥XT2 Σ(θ0)X1(XT1 Σ(θ0)X1)−1∥∥∞ ≤ K (dn/τ + 1) .
This condition is similar to the irrepresentable condition of Lasso because when
τ = O(1), dn/τ+1→ 1. Therefore, asymptotically SICAλn and Logλn would perform
in a way similar to Lasso. If dn  ηp, then SICAλn and Logλn cannot simultaneously
satisfy conditions 3.1 and 3.3, even if the irrepresentable condition is satisfied.
By Proposition 4, tuning both λn and τn significantly improves the performance
of SICA and Log. Specifically, SICA and Log can have satisfactory variable selection
performances even if the minimum effect size is much smaller with respect to the di-
mension of the problem: dn  ηp. This can be justified by the following arguments.
For Log penalty, p′$(dn) = p
′
$(0+)/(dn/τn + 1). Even condition 3.3 requires a large
value of p′$(0+); a small enough τn can help p
′
$(dn) to satisfy condition 3.1. SICA
has similar properties since it has p′$(dn) = p
′
$(0+)/(dn/τn + 1)
2. Therefore, the
implications of Proposition 3 and Proposition 4 for the practical use of SICA and
Log penalties would be that we should not treat τ as a constant.
Corollary 1 shows that for a difficult variable selection problem where dn  ηp,
the tuning parameter an of MCP or τn of SICA or Log should be on the scale of o(1).
Zhang [2010] suggests that a larger tuning parameter a in MCP leads to a bigger bias
and less accurate variable selection, a = 1 leads to a singularity problem, and a < 1
leads to a dramatic increase in computational cost. Similarly, Lv and Fan [2009]
suggest that for penalized estimates using SICA, the bias decreases to 0 as τn goes
to 0+, but the computational difficulty increases because the maximum concavity
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goes to infinity. Similar conclusions apply to the Log penalty. Although MCPλn,an ,
SICAλn,τn , and Logλn,τn have similar theoretical properties by Propositions 2 and 4,
the following numerical studies show that the computation cost for SICA and Log is
more affordable than that of MCP.
2.3 Algorithm and tuning parameter selection
We obtain the penalized estimates using SCAD or MCP by the coordinate descent
algorithms implemented in the R package ncvreg [Breheny and Huang, 2011]. We
implement the penalized estimation using SICA and Log penalties by a combination
of the coordinate descent algorithm and Local Linear Approximation (LLA) [Zou
and Li, 2008]. Specifically, we update the estimate of each regression coefficient
sequentially (which is the coordinate decent part), and the solution of each coefficient
is obtained after applying a local linear approximation:
p$ (|βj|) ≈ p$
(
|βˆ(k)j |
)
+ p′$
(
|βˆ(k)j |
)(
|βj| − |βˆ(k)j |
)
,
where βˆ
(k)
j is the estimate of regression coefficient βj at the k-th iteration.
We present the computational algorithms for linear and logistic regression sepa-
rately. The objective function for linear regression is:
Qn(β) = − 1
2n
(y −Xβ)T (y −Xβ)−
p∑
j=1
p$(|βj|).
After applying LLA for the penalty function, the objective function to be maximized
at the (k + 1)-th step, while solving for βj, is
Q(k+1)n (βj) = −
1
2n
‖y −X−jβˆ(k)−j − xjβj‖2 +
p∑
j=1
p′$
(
|βˆ(k)j |
)
|βj|,
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where X−j is the matrix X without the jth column, and βˆ
(k)
−j is βˆ
(k) without the jth
element. By letting ∂Q
(k+1)
n (βj)/∂βj = 0, we can obtain the solution for βj βˆ
(k+1)
j = 0 if |z(k)j | ≤ v−1j p′$
(
|βˆ(k)j |
)
βˆ
(k+1)
j = sgn(βˆ
(k
j )
[
|z(k)j | − v−1j p′$
(
|βˆ(k)j |
)]
if |z(k)j | > v−1j p′$
(
|βˆ(k)j |
) ,
where z
(k)
j = xj(y −X−jβ(k)−j )/vj, and vj = xTj xj.
The penalized likelihood for logistic regression is
Qn(β) =
1
n
n∑
i=1
{
yi log
pii
1− pii + log (1− pii)
}
−
p∑
j=1
p$(|βj|),
where pii = Pr(yi = 1). By applying the iteratively reweighted least squares algorithm
[McCullagh and Nelder, 1989] and the LLA of the penalty function, the objective
function to be maximized at the (k + 1)-th step, while solving for βj, is
Q(k+1)n (βj) ≈ −
1
2n
(
y˜(k) −X−jβˆ(k)−j − xjβj
)T
W (k)
(
y˜(k) −X−jβˆ(k)−j − xjβj
)
+
p∑
j=1
p′$
(
|βˆ(k)j |
)
|βj|,
where y˜(k) = Xβˆ(k) +
(
W (k)
)−1
(y − pi(k)), W (k) is a diagonal matrix with the i-th
diagonal element w
(k)
i = pi
(k)
i (1− pi(k)i ), and pi(k)i = exp
(
Xβˆ(k)
)
/
[
1 + exp
(
Xβˆ(k)
)]
.
Letting ∂Q
(k+1)
n (βj)/∂βj = 0, the estimate of βj is βˆ
(k+1)
j = 0 if |z(k)j | ≤ v−1j p′$
(
|βˆ(k)j |
)
βˆ
(k+1)
j = sgn(βˆ
(k
j )
[
|z(k)j | − v−1j p′$
(
|βˆ(k)j |
)]
if |z(k)j | > v−1j p′$
(
|βˆ(k)j |
) ,
where z
(k)
j = x
T
jW
(k)(y˜(k) −X−jβ(k)−j ) and vj = xTjW (k)xj.
The iterative estimation process ends if the maximum difference of the estimates
of β between consecutive iterations is less than 10−5.
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We follow a strategy similar to the ones in Breheny and Huang [2011] to obtain
an initial set of tuning parameter combinations. For SCAD and MCP, the tuning
parameter a is given as a constant or a vector of legitimate values such as a > 2 for
SCAD and a > 1 for MCP (the implementation of MCP in the R package ncvreg
requires a > 1). The λ’s for SCAD and MCP are given as N numbers equally spaced
on a log scale, with the largest one corresponding to the largest marginal effect size
and the smallest one being a fraction of the largest one. In our experience, the frac-
tion is set as 1/10 from the linear model, and 1/100 for the logistic model.
For SICA and Log, the tuning parameter τ is set as a constant or a vector of
legitimate values such as τ > 0. The theoretical results in previous sections suggest
that τ should be much smaller than the minimum effect size. In practice, because we
do not know which set of variables is important, we use the largest marginal effect size
as the upper bound for τ . Neither λ nor τ alone determines the penalization strength.
Instead, their combination in the form of the threshold v−1j p
′
$(|βˆ(k)j |) specifies the
penalization strength. Without loss of generality, we assume xj (j = 1, ..., p) is
standardized with mean 0 and vj =
∑n
i=1 x
T
ijxij = n. It follows that the thresholds
for SICA and the Log penalties are p′$ (0) /vj = p
′
$ (0) /n. The largest threshold
corresponds to the largest marginal coefficient estimates (by absolute value), denoted
by βˆM , a predefined number of τ ’s uniformly distributed on a log scale from 10
−6 to
βˆM , and the smallest threshold is 1/10 of the largest one, i.e., βˆM/10 for the linear
model, and 1/100 for the logistic model respectively:
{Threshold1, ..., ThresholdN} =
{
βˆM , ...,
βˆM
100
}
.
For example, for Log penalty, the threshold in the first iteration is λ/(nτ). Then
given a specific value of τ and a set of thresholds, N λ’s can be generated based on
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the equation:
{λ1/nτ, ..., λN/nτ} = {Threshold1, ..., ThresholdN} .
A similar strategy is used to determine the initial set of tuning parameters for SICA.
We select a particular combination of tuning parameters from the initial tuning
parameter pool using the extended BIC [Chen and Chen, 2008, 2012]. As discussed
in Chen and Chen [2008], if log p/log n > 0.5, the conventional BIC [Schwarz, 1978]
is not consistent. In all the scenarios considered in this paper, log p/ log n > 1. Our
empirical studies confirm that in these scenarios the conventional BIC tends to be
too liberal, and the extended BIC performs satisfactorily. The extended BIC for the
linear model m is:
BIC%(m) = −2 log ln{θˆ(m)}+ dfm log n+ 2% log ς(Sdfm),
where dfm is the degrees of freedom for model m and ς(Sdfm) is the number of the
models containing dfm covariates. We take the number of the nonzero coefficient
estimates in the model m as dfm and set ς(Sdfm) =
(
p
dfm
)
, the number of combinations
of dfm covariates chosen from p covariates. In addition, we set % ' 1−1/(2log p/log n)
while % > 1 − 1/(2log p/log n) is suggested in Chen and Chen [2008]. The extended
BIC for a generalized linear model m is:
BIC%(m) = −2 log ln{θˆ(m)}+ dfm log n+ 2dfm% log p,
where dfm is the number of nonzero coefficient estimates, and similar to the above
% ' 1− 1/(2log p/log n), as suggested in Chen and Chen [2012].
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2.4 Simulation
We evaluated those four penalties using a set of simulated data for multiple loci
mapping problems. Specifically, the response variable is either a continuous trait
(linear regression) or the case/control status (logistic regression), and the covari-
ates are the genotypes of the SNPs. One particular challenge in a multiple loci
mapping problem is that nearby SNPs often have correlated genotypes due to link-
age disequilibrium, and such correlations may violate the irrepresentable condition,
which is needed for the consistency of Lasso. To faithfully reproduce such correla-
tion structure, we directly used genotype data of European Ancestry (EA) samples
from a GWAS study of schizophrenia [Shi et al., 2009]. The dataset was obtained
from NCBI dbGaP, which includes GAIN (Genetic Association Information Network)
samples (2,686/2,656: cases/controls, dbGaP Accession: phs000021.v3.p2) and non-
GAIN samples (1,217/1,442: cases/controls, dbGaP Accession: phs000167.v1.p1)
genotyped by Affymetrix 6.0 SNP arrays with ∼900,000 SNPs.
To compare the performances of those penalty functions, we use two criteria to
select the tuning parameters. One is the extended BIC as introduced earlier, and
the other is an oracle criterion that uses the knowledge of the true model to select
the tuning parameters. Certainly the oracle criterion is not applicable in practice
when the true model is unknown. However, in simulation studies, the oracle criterion
permits us to evaluate the performance of a penalty function rather than the combined
outcome of a penalty function and a tuning parameter selection method. The oracle
criterion is defined as follows. Let D be the number of discoveries, i.e., the covariates
with non-zero regression coefficient estimates. D = TD + FD, where TD and FD are the
number of true discoveries and false discoveries, respectively. Our oracle criterion
evaluates a model based on the three measures, the false discovery rate FD/D, power
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TD/s, and the sum of squared error of regression coefficient estimates
∑p
j=1 |βˆj −
β0j|2, where β0j is the true value of βj. The model with the minimum of wt(FD/D−
TD/s) +
∑p
j=1 |βˆj − β0j|2 is selected, where wt is a weight to balance the number of
true/false discoveries and bias. Models selected with larger wt tend to have more
true discoveries and fewer false discoveries, but have a larger bias in their regression
coefficient estimates.
2.4.1 Linear model
For computational efficiency when there are a large number of simulations, we
randomly selected n = 222 samples and 12,656 SNPs with no missing values, and
with a minor allele frequency greater than 5% on chromosome 20. The response
variables y were simulated by y = Xβ + , where  ∼ N(0, In×n). We considered 3
situations involving different combinations of p and s: p = 12,656 and s = 12, 16, or
20. Let uT1 = (0.5,−0.5, 0.4,−0.4). When s = 12, 16, and 20, β0 are set by repeating
u1 three, four, and five times, respectively. In addition, we considered null situations
with s = 0 and p = 12,656.
The tuning parameter grids were chosen as follows: a = (2.1, 2.5, 3.0, 3.7, 4.5,
6.0) for SCAD, a = (1.1, 2.0, 3.0, 4.0, 5.0, 6.0) for MCP, and 6 τ ’s for Log and SICA
as described in the section 3. We also applied Lasso implemented in R/glmnet.
For each of these five penalties, 100 λ’s uniformly distributed on a log scale were
generated as described in section 3.
We used the extended BIC and oracle criteria 10(FD/D− TD/s) +∑pj=1 |βˆj − βj0|2
to select the tuning parameters. We give the term (FD/D − TD/s) a larger weight
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of 10 so that the oracle criterion selects the model with the smaller false discovery
rate FD/D, greater power TD/s first, and use the sum of squared error of regression
coefficient estimates
∑p
j=1 |βˆj − βj0|2 as a secondary criterion.
For null simulation situations, all penalties have at most 1 or 2 false discoveries
by the extended BIC tuning parameter selection criterion. Table 2.1 summarizes
the simulation results in non-null situations with 12, 16, or 20 important covariates.
The folded concave penalties perform better than the Lasso penalty. Among the
four folded concave penalties, SICA, Log and MCP have comparable performance,
and are better than SCAD when the tuning parameters are selected by the oracle
criterion. When the tuning parameters are selected by the extended BIC, SICA
and Log have comparable performance, and are better than SCAD and MCP. In
additional simulation studies (results not shown), SCAD and MCP with one tuning
parameter (λ) have slightly worse performance than the situations with two tuning
parameters. In contrast, Log and SICA with one tuning parameter (λ) have much
worse performance than the situations with two tuning parameters. Therefore, the
extra tuning parameter (a or τ) gives SCAD and MCP limited additional advantage,
but significantly improves the performances of Log and SICA.
Table 2.1: Simulation results for penalized linear regression with (n=222, p = 12,656).
The headers indicate the tuning parameter selection criterion (Oracle or the extended
BIC) and the numbers in parentheses are the number of important covariates. For
each penalty, we present the median of the number of true discoveries, false discoveries
(in parentheses), and average bias of the true discoveries (in brackets) across 100
simulations.
Oracle (12) Ext BIC (12) Oracle (16) Ext BIC (16) Oracle (20) Ext BIC (20)
Lasso 11 (8) [0.33] 0 (0) [−] 7 (3) [0.39] 0 (0) [−] 14 (112) [0.34] 0 (0) [−]
SCAD 11 (3) [0.28] 0 (0) [−] 15 (25) [0.13] 0 (0) [−] 19 (27) [0.12] 0 (0) [−]
MCP 11 (1) [0.08] 10 (20) [0.08] 14 (2) [0.07] 11 (39) [0.10] 17 (3) [0.08] 5 (39) [0.11]
Log 11 (1) [0.07] 10 (3) [0.07] 14 (3) [0.07] 11 (7) [0.07] 17 (3) [0.08] 8 (10) [0.08]
SICA 11 (1) [0.06] 10 (3) [0.06] 14 (2) [0.06] 11 (6) [0.07] 17 (4) [0.07] 5 (7) [0.08]
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2.4.2 Simulation for logistic model
For penalized logistic regression, a larger sample size is needed for simulations
with reasonable effect sizes. We randomly selected 10,156 SNPs (with a minor allele
frequency larger than 5%) from chromosomes 1 to 22 and X and 750 samples (with
a missing values percent smaller than 3%). We simulated the individual SNP effect
so that the disease odds ratios are 2.0, corresponding to regression coefficients of
0.7. The binary response variable y was simulated based on the logistic regression
model: log{Pr(y = 1)/Pr(y = 0)} = Xβ, where s = 4, 8, or 12. In addition, the
null model where s = 0 was simulated. The intercept was set as −2, corresponding
to a disease prevalence of 0.12. The initial pool of tuning parameters were gen-
erated in the same way as linear regression, and then a particular combination of
tuning parameters was selected to minimize the extended BIC, or an oracle criterion
10(FD/D− TD/s) +∑pj=1 |βˆj − βj0|2.
For the simulation of null models, all penalties have at most 1 or 2 false discover-
ies by the extended BIC tuning parameter selection criterion. The simulation results
of non-null models are shown in Table 2.2. In general, the results of logistic model
simulation have a trend similar to that of linear model simulation. When the oracle
criterion is used, all penalties have satisfactory variable selection performances, al-
though SICA and Log have a smaller bias on effect size estimation. It can be observed
that the models chosen by the oracle criterion are different from those selected by
the extended BIC for SCAD and MCP. This is because the models chosen by the
oracle criterion tend to have larger biases, which reduces the likelihood, and thus
increases the realized value of the extended BIC. On the other hand, for Log and
SICA, the models chosen by the oracle criterion are similar to those chosen by the
extended BIC. Additional simulations (results not shown) confirm that SCAD with
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one or two tuning parameters have similar performance, and an additional tuning
parameter improves MCP’s performance. Moreover, the additional tuning parameter
significantly improves the performance of the SICA and Log penalties.
Finally, Table 2.3 presents the comparison of the computational burden for MCP,
Log and SICA across various values of a and τ , respectively. It can be observed that
the computation time of Log and SICA is much less than that of MCP.
In summary, Log and SICA have a smaller bias for the coefficient estimates of
important covariates, and therefore, more accurate estimates of the likelihood func-
tion. In addition, they have lower computational burden compared to MCP. As a
consequence, Log and SICA penalties have advantages in empirical usage.
Table 2.2: Simulation results for penalized logistic regression (n=750, p = 10,156).
The headers indicate the tuning parameter selection criterion (Oracle or the extended
BIC) and the numbers in parentheses are the number of important covariates. For
each penalty, we present the median of the number of true discoveries, the number of
false discoveries (in parentheses), and the average bias of true discoveries (in brackets)
across 100 simulations.
Oracle (4) Ext BIC (4) Oracle (8) Ext BIC (8) Oracle (12) Ext BIC (12)
Lasso 4(0) [0.49] 4 (0) [0.47] 7(0) [0.55] 6 (0) [0.53] 11(2) [0.59] 0 (0) [−]
SCAD 4 (0) [0.48] 4 (0) [0.39] 7 (0) [0.53] 6 (0) [0.43] 11(2) [0.58] 0 (0) [−]
MCP 4 (0) [0.093] 4 (0) [0.097] 7 (0) [0.25] 6 (1) [0.14] 11(1) [0.32] 11 (7) [0.25]
Log 4 (0) [0.085] 4 (0) [0.096] 7 (0) [0.085] 7 (1) [0.09] 11(1) [0.10] 11 (1) [0.10]
SICA 4 (0) [0.084] 4 (0) [0.094] 7 (0) [0.095] 7 (1) [0.099] 11(1) [0.12] 11 (1) [0.096]
Table 2.3: Running time rounded to minutes per simulation (n=750, s = 12, p =
10,156) for 100 λ’s and a fixed a of MCP or τ of Log and SICA.
MCP 21.1 (a = 1.1) 5.2 (a = 2.0) 7.1 (a = 3.0) 6.3 (a = 4.0) 9.7 (a = 5.0)
Log 2.1 (τ = 10−6) 1.9 (τ = 10−5) 1.9 (τ = 10−4) 1.9 (τ = 10−3) 1.8 (τ = 0.6)
SICA 2.0 (τ = 10−6) 2.1 (τ = 10−5) 1.9 (τ = 10−4) 1.8 (τ = 10−3) 1.8 (τ = 0.6)
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2.5 Real data analysis
We analyzed the data of GWA studies of schizophrenia on European-ancestry sam-
ples (2,195 cases vs. 2,617 controls). The missing genotypic data were imputed using
BEAGLE software [Browning and Browning, 2007], and 677,163 autosome SNPs with
minor allele frequency no less than 5% were selected for the analysis. We included
23 principle components (PCs) of genotype data in the model to account for possible
population stratification. First, a univariate logistic regression is conducted on the
case-control status for each of the 677,163 SNPs, conditioning on the covariates: age,
gender and 23 PCs. Using the resulting 677,163 p-values, we calculated a genomic
control factor of 1.0445 [Devlin and Roeder, 1999], implying that there is no strong
population stratification not accounted for in our model. The 7,984 SNPs with p-
values smaller than 0.01 were selected for the following variable selection. We applied
the penalized logistic regression on the 7,984 SNPs and 4,812 samples with the four
folded-concave penalties, while accounting for the effects of age, gender and 23 PCs,
by including them as unpenalized covariates.
We applied SCAD with a = 3.7 and MCP with a = 3, the default value of R pack-
age ncvreg, and chose to use two tuning parameters for SICA and Log. Using the
extended BIC for tuning parameter selection, the penalized logistic regressions with
Log and SICA selected 38 and 22 SNPs, respectively (Supplementary Table 1-2).
However, penalized logistic regressions with both MCP and SCAD selected the null
model since the null model has the lowest value of the extended BIC.
A joint model was fitted by a logistic regression using the 38 SNPs identified by the
Log penalty together with age, gender, and 23 PCs to obtain the p-values for the 38
SNPs. The results are illustrated in Figure 3.5, together with the marginal p-values
for the 677,163 SNPs. There are 43 genes within 10kb distance of these 38 SNPs,
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and among them 21 are in the Database for Annotation, Visualization and Integrated
Discovery (DAVID) [Huang et al., 2008]. By functional category enrichment analysis
at the DAVID website, 16 of the 21 genes are bound by transcription factor FOXO1,
with significant enrichment p-value after a Benjamini correction. Recent studies have
shown that FOXO1 regulates neuroblastoma differentiation [Mei et al., 2012], which
is relevant to schizophrenia. In contrast, we also did the functional category analysis
for those genes within 10 kb of the 38 SNPs with the smallest marginal p-values, but
no functional category was significantly over-represented.
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Figure 2.2: GWA marginal p-values (colored circles) and the 38 SNPs (black crosses)
identified by penalized logistic regression using Log penalty.
2.6 Asymptotic results
We present the following Theorem 1 of Fan and Lv [2011] for the self-completeness
of this paper. This Theorem gives a set of sufficient and almost necessary conditions
of a local maximizer of the penalized likelihood.
Theorem 1. (Characterization of PMLE): βˆ ∈ Rp is a strict local maximizer of
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the non-concave penalized likelihood Qn(β) = ln(β)−
∑p
j=1 p$(|βj|) if
XT1 µ(θˆ)−XT1 y + np′$(βˆ01) = 0 (2.6.1)
‖XT2 (y − µ(θˆ))‖∞ − np′$(0+) < 0 (2.6.2)
λmin
(
XT1 Σ(θˆ)X1
)
− nκ(p$, βˆ01) > 0. (2.6.3)
The following conditions 4.1-4.4 are for the design matrix X, and they are es-
sentially the same as the corresponding conditions from Fan and Lv [2011]. We
first define a few notations used in the following regularity conditions. L∞ norm
of a matrix is the maximum of the L1 norm of each row. λmax()/λmin() denotes
the maximum/minimum eigen-value of a symmetric matrix, respectively. Denote a
neighborhood of the non-zero coefficients as N0 = {δ ∈ Rs : ‖δ − β01‖∞ ≤ dn}.
Condition 4.1. ‖[XT1 Σ(θ0)X1]−1‖∞ = O(bsn−1), where
bs = O(n
γs) min(n1/2−γ0 , nγ0−ν(log n)−1/2) and γs ≥ 0.
Condition 4.2 maxδ∈N0 max
p
j=1 λmax[X
T
1 |xj|diag{|µ′′(X1δ)|}X1] = O(n), where the
derivative µ′′(X1δ) is taken component-wise.
Condition 4.3 maxpj=1 ||xj||∞ = o(n(1−α)/2(log n)−1/2) if the responses are unbounded.
Condition 4.4 maxδ∈N0 κ(p$, δ) ≤ minδ∈N0 λmin[n−1XT1 Σ(X1δ)X1], where κ(p$, δ) is
defined as the local concavity of a penalty function at v = (v1, ..., vq)
T:
κ(p$, v) = lim
→0+
max
1≤j≤q
sup
t1<t2∈(|vj |−,|vj |+)
−p
′
$(t2)− p′$(t1)
t2 − t1 .
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For the penalties with continuous second derivatives, κ(p$, v) = max1≤j≤q−p′′$(vj).
Given conditions 1 to 4, we have the following weak oracle property.
Theorem 2. (Weak oracle property) Given the conditions 1 to 4, with probability
at least Pconverage = 1−2 [sn−1 + (p− s) exp (−nα log n)] , there exists a penalized
likelihood estimator βˆ = (βˆT1 , βˆ
T
2 )
T which satisfies
(a) Sparsity: P (βˆ2 = 0)→ 1, (b) L∞ loss: ‖βˆ1 − β10‖∞ = o(n−γ0
√
log n).
Lemma 1 (for proofs of the propositions 2 and 3)
For condition 3.3, if s = O(nν) min(nγ0/2(log n)−1/4, n−γ0+1/2), then
max(n−2γ0+2ν log n, nν−1/2
√
log n) n−γ0
√
log n = O(dn). (2.6.4)
Proof:
If 1/3 < γ0 < 1/2, then min(n
γ0/2(log n)−1/4, n−γ0+1/2) = n−γ0+1/2
max(n−2γ0+2ν log n, nν−1/2
√
log n) = max(s2n−2γ0 log n, sn−1/2
√
log n)
 max(n1−4γ0 log n, n−γ0
√
log n)
= n−γ0
√
log n = O(dn).
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If 0 ≤ γ0 ≤ 1/3, then min(nγ0/2(log n)−1/4, n−γ0+1/2) = nγ0/2(log n)−1/4,
max(n−2γ0+2ν log n, nν−1/2
√
log n) = max(s2n−2γ0 log n, sn−1/2
√
log n)
 max(n−γ0
√
log n, nγ0/2−1/2(log n)1/4)
= n−γ0
√
log n = O(dn).
Therefore, max(n−2γ0+2ν log n, nν−1/2
√
log n) n−γ0√log n = O(dn).
Lemma 2 (for proofs of propositions 2 and 3)
For condition 3.3, if s min(nγ0/2−γs/2(log n)−1/4, n−γ0−γs+1/2), then
max(n−2γ0+2ν log n, nν−1/2
√
log n) n−γ0−γs
√
log n = O(b−1s dn). (2.6.5)
Proof:
If γ0 +γs/3 > 1/3, then min(n
γ0/2−γs/2(log n)−1/4, n−γ0−γs+1/2) = n−γ0−γs+1/2, and
max(n−2γ0+2ν log n, nν−1/2
√
log n) = max(s2n−2γ0 log n, sn−1/2
√
log n)
 max(n1−4γ0−2γs log n, n−γ0−γs
√
log n)
= n−γ0−γs
√
log n = O(b−1s dn).
If 0 ≤ γ0+γs/3 ≤ 1/3, then min(n
γ0
2
− γs
2 (log n)−1/4, n−γ0−γs+1/2) = nγ0/2−γs/2(log n)−1/4,
and
max(n−2γ0+2ν log n, nν−1/2
√
log n) = max(s2n−2γ0 log n, sn−1/2
√
log n)
 max(n−γ0−γs
√
log n, nγ0/2−γs/2−1/2(log n)1/4).
= n−γ0−γs
√
log n = O(b−1s dn).
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Thus max(n−2γ0+2ν log n, nν−1/2
√
log n) n−γ0−γs√log n = O(b−1s dn)
Proof of Proposition 1
For SCAD:
• Given dn  ηp and s  ηd, we will show that if λn = O(dn) and dn ≥ aλn
(more precisely, dn ≥ aλn for SCADλn or dn ≥ anλn for SCADλn,an), conditions
3.1-3.3 and 4.4 are satisfied.
– Since dn ≥ aλn, p′SCADλn (dn) = p′SCADλn,an (dn) = 0. Therefore condition 3.1
is satisfied.
– Because p′SCADλn (0+) = p
′
SCADλn,an
(0+) = λn, condition 3.3 becomes
λn >
σ−1/2
(1−K)n
−1/2+α/2√log n and λn  max(n−2γ0+2ν log n, nν−1/2√log n).
First, λn >
σ−1/2
(1−K)n
−1/2+α/2√log n by our choice of λn = O(dn), and the
assumption
dn  n−1/2+α/2
√
log n. Next, λn  max(n−2γ0+2ν log n, nν−1/2
√
log n) is
satisfied by Lemma 1, and the choice of λn = O(dn). Therefore condition
3.3 is satisfied.
– For either SCADλn or SCADλn,an , we have p
′
$(0+)/p
′
$(dn) = ∞ because
p′$(0+) > 0 and p
′
$(dn) = 0. Therefore condition 3.2 is satisfied.
– For any δ = (δ1, ..., δs)
T ∈ N0 ≡ {δ ∈ Rs : ‖δ − β01‖∞ ≤ dn}, we have
|δj| ≥ dn ≥ aλn, and thus κ(p$, δj) = 0 for either SCADλn or SCADλn,an .
Therefore condition 4.4 is satisfied.
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• Given dn  O(n−1/2+α/2
√
log n),
– Condition 3.3 requires λn >
σ−1/2
(1−K)n
−1/2+α/2√log n. Given dn  n−1/2+α/2
√
log n,
we have dn  λn. Therefore, p′SCADλn (dn) = p′SCADλn,an (dn) = λn.
– Condition 3.1 requires p′$(dn) = λn  dn since b−1s dn  dn.
Clearly, no such λn exists to satisfy dn  λn and dn  λn or dn < λn
simultaneously.
For MCPλn :
• Given dn  σ−1/2(1−K)n−1/2+α/2
√
log n and s  min(nγ0/2(log n)−1/4, n−γ0+1/2), we
will show that if λn = O(dn) and dn ≥ aλn, conditions 3.1-3.3 and 4.4 are
satisfied.
– Since dn ≥ aλn, p′MCPλn (dn) = 0. Therefore condition 3.1 is satisfied.
– Because p′MCPλn (0+) = λn, condition 3.3 becomes
λn >
σ−1/2
(1−K)n
−1/2+α/2√log n and λn  max(n−2γ0+2ν log n, nν−1/2√log n).
First, λn >
σ−1/2
(1−K)n
−1/2+α/2√log n by our choice of λn. Next, by Lemma 1,
λn  max(n−2γ0+2ν log n, nν−1/2
√
log n) because λn = O(dn). Therefore
condition 3.3 is satisfied.
– For MCPλn , p
′
MCP(0+)/p
′
MCP(dn) =∞ because p′MCP(0+) > 0 and p′MCP(dn) = 0.
Therefore condition 3.2 is satisfied.
– Because dn ≥ aλn, κ(p$, δ) = 0 for any δ ∈ N0 ≡ {δ ∈ Rs : ‖δ − β01‖∞ ≤ dn}.
Thus condition 4.4 is satisfied.
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• Given dn  O(n−1/2+α/2
√
log n),
– Condition 3.3 requires λn >
σ−1/2
(1−K)n
− 1
2
+α
2
√
log n. Given dn  n− 12+α2
√
log n,
it leads dn  λn or dn < λn. Therefore, p′MCPλn (dn) = λn.
– Condition 3.1 requires p′$(dn) = λn  dn since b−1s dn  dn.
Clearly, no such λn exists to satisfy both conditions simultaneously.
Proof of Proposition 2
For MCPλn,an , we will show that if (λn, an) satisfy λn > ηp,
λn  max(n−2γ0+2ν log n, nν−1/2
√
log n)
, and anλn < dn, conditions 3.1-3.3 and 4.4 are satisfied.
• Since dn ≥ anλn, p′MCPλn,an (dn) = 0. Therefore, condition 3.1 is satisfied.
• Because p′MCPλn,an (0+) = λn, condition 3.3 becomes
λn >
σ−1/2
(1−K)n
−1/2+α/2√log n and λn  max(n−2γ0+2ν log n, nν−1/2√log n).
By our choice of λn, condition 3.3 is satisfied.
• For MCPλn,an , p′MCP(0+)/p′MCP(dn) = ∞ because p′MCP(0+) > 0 and p′MCP(dn) = 0.
Therefore condition 3.2 is satisfied.
• Because dn ≥ aλn, κ(p$, δ) = 0 for any δ ∈ N0 ≡ {δ ∈ Rs : ‖δ − β01‖∞ ≤ dn}.
Thus condition 4.4 is satisfied.
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Proof of Proposition 3
For SICAλn :
• p′SICAλn (0+) = λn(1 + 1/τ) = O(λn) and p′SICAλn (dn) =
λnτ(τ+1)
(dn+τ)2
= O(λn).
Because s  min(nγ0/2−γs/2(log n)−1/4, n−γ0−γs+1/2) and α < 1− 2γ0 − 2γs, we
have
max(n−1/2+α/2
√
log n, n−2γ0+2ν log n, nν−1/2
√
log n) n−γs−γ0
√
log n
by Lemma 2. In addition, given
∥∥XT2 Σ(θ0)X1(XT1 Σ(θ0)X1)−1∥∥∞ ≤ K (dn/τ + 1)2,
we will show that if
max(n−1/2+α/2
√
log n, n−2γ0+2ν(log n)2, nν−1/2
√
log n) λn  n−γs−γ0
√
log n,
conditions 3.1-3.3 and 4.4 are satisfied.
– Since p′SICAλn (dn) = O(λn) n−γs−γ0
√
log n, condition 3.1 is satisfied.
– Because p′SICAλn (0+) = O(λn) by the choice of λn, condition 3.3 is satisfied
by
max(n−1/2+α/2
√
log n, n−2γ0+2ν(log n)2, nν−1/2
√
log n) λn
– Since p′SICAλn (0+)/p
′
SICAλn
(dn) = (dn/τ + 1)
2, condition 3.2 is satisfied by
∥∥XT2 Σ(θ0)X1(XT1 Σ(θ0)X1)−1∥∥∞ ≤ K (dnτ + 1
)2
.
– Because p′′SICAλn (dn) = O(λn) = o(1), condition 4.4 is satisfied.
• Given dn  O(n−1/2+α/2
√
log n),
– Condition 3.3 requires p′SICAλn (0+) = O(λn) >
σ−1/2
(1−K)n
− 1
2
+α
2
√
log n. Given
dn  n− 12+α2
√
log n, it leads dn  λn. Therefore, p′SICAλn (dn) = O(λn).
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– Condition 3.1 requires p′$(dn) = λn  dn since b−1s dn  dn.
Clearly, no such λn exists to satisfy both conditions simultaneously.
For Logλn :
• p′Logλn (0+) = λn/τ = O(λn) and p
′
Logλn
(dn) = λn/(dn + τ) = O(λn).
Given α < 1 − 2γ0 − 2γs and s  min(nγ0/2−γs/2(log n)−1/4, n−γ0−γs+1/2), by
Lemma 2, we have
max(n−1/2+α/2
√
log n, n−2γ0+2ν log n, nν−1/2
√
log n) n−γs−γ0
√
log n.
Given the additional condition
∥∥XT2 Σ(θ0)X1(XT1 Σ(θ0)X1)−1∥∥∞ ≤ K (dn/τ + 1),
we will show that if
max(n−1/2+α/2
√
log n, n−2γ0+2ν log n, nν−1/2
√
log n) λn  n−γs−γ0
√
log n,
conditions 3.1-3.3 and 4.4 are satisfied.
– Since p′Logλn (dn) = O(λn)  n
−γs−γ0√log n by the choice of λn, condition
3.1 is satisfied.
– Because p′Logλn (0+) = O(λn), by the choice of λn, condition 3.3 is satisfied
by
max(n−1/2+α/2
√
log n, n−2γ0+2ν log n, nν−1/2
√
log n) λn.
– Since p′Logλn (0+)/p
′
Logλn
(dn) = dn/τ + 1, condition 3.2 is satisfied given
∥∥XT2 Σ(θ0)X1(XT1 Σ(θ0)X1)−1∥∥∞ ≤ K (dnτ + 1
)
.
– Because p′′Logλn (dn) = O(λn) = o(1), condition 4.4 is satisfied.
• Given dn  O(n−1/2+α/2
√
log n),
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– Condition 3.3 requires p′Logλn (0+) = O(λn) >
σ−1/2
(1−K)n
− 1
2
+α
2
√
log n. Given
dn  n− 12+α2
√
log n, it leads dn  λn. Therefore, p′Logλn (dn) = O(λn).
– Condition 3.1 requires p′$(dn) = λn  dn since b−1s dn  dn.
Clearly, no such λn exists to satisfy both conditions simultaneously.
Proof of Proposition 4
For SICAλn,an :
• Let λn = O(nγλ) and τn = O(nγτ ). Given 0 < α < 1 and ν ≤ γ0, we will show
that if γτ < −2γ0 − γs < γλ < −γ0, conditions 3.1-3.3 and 4.4 are satisfied.
– Given γτ < −γ0, ∃ constant C such that dn + τn ≥ C−1n−γ0 . Therefore
p′SICAλn,an (dn) =
λnτn(τn + 1)
(dn + τn)2
≤ C2n2γ0λnτn(τn + 1) = O(n2γ0+γλ+γτ ),
κ(p$, δ) = |p′′SICAλn,τn (dn)| =
2λnτn(τn + 1)
(dn + τn)3
≤ 2C3n3γ0λnτn(τn + 1)
= O(n3γ0+γλ+γτ ).
– p′SICAλn,an (dn) = O(n
2γ0+γλ+γτ ) b−1s dn = O(n−γs−γ0
√
log n) by the choice
of λn, τn with γλ + γτ < −3γ0 − γs. Therefore, condition 3.1 is satisfied.
– Since p′SICAλn,τn (0+) = O(n
γλ−γτ ), condition 3.3 becomes
nγλ−γτ  max(n−2γ0+2ν log n, nν−1/2
√
log n)
and
nγλ−γτ >
σ−1/2
(1−K)n
−1/2+α/2√log n.
Given 0 ≤ α < 1 and ν < γ0 < 1/2 (conditions 2.1 and 2.2),
max
(
σ−1/2
(1−K)n
−1/2+α/2√log n, n−2γ0+2ν log n, nν−1/2√log n) log n
and nγλ−γτ  log n by γλ − γτ > 0. Thus condition 3.3 is satisfied.
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– By conditions 2.1 and 2.2, 0 ≤ ν < γ0 < 1/2, thus γτ < −2γ0 < −γ0−ν/2.
Thus
p′SICAλn,τn
(0+)
p′SICAλn,τn
(dn)
= (dn/τn+1)
2 = O(n−2γ0−2γτ log n) O(nv). Therefore
condition 3.2 is satisfied
– Condition 4.4 is fulfilled by κ(p$, δ) = |p′′SICAλn,τn (dn)| = O(n3γ0+γλ+γτ ) =
o(1) because γτ + γλ < −3γ0.
For Logλn,an :
• Given 0 < α < 1 and ν ≤ γ0, we will show that if γτ < γλ < −2γ0 − γs,
conditions 3.1-3.3 and 4.4 are satisfied. Given γτ < −γ0, ∃ constant C such
that dn + τn ≥ C−1n−γ0 . Therefore
p′Logλn,τn (dn) = λn/(dn + τn) ≤ Cn
γ0λn = O(n
γ0+γλ)
κ(p$, δ) = |p′′Logλn,τn (dn)| = λn/(dn + τn)
2 ≤ C2n2γ0λn = O(n2γ0+γλ).
– p′Logλn,τn (dn) = O(n
γ0+γλ)  b−1s dn = O(n−γs−γ0
√
log n) by the choice of
λn with γλ < −2γ0 − γs. Therefore, condition 3.1 is satisfied.
– Since p′Logλn (0+) = λn/τn = O(n
γλ−γτ ). Condition 3.3 becomes
nγλ−γτ  max(n−2γ0+2ν log n, nν−1/2
√
log n)
and
nγλ−γτ >
σ−1/2
(1−K)n
−1/2+α/2√log n.
Given 0 ≤ α < 1 and ν < γ0 < 1/2 (conditions 2.1 and 2.2),
max
(
σ−1/2
(1−K)n
−1/2+α/2√log n, n−2γ0+2ν log n, nν−1/2√log n) log n.
Because γλ − γτ > 0, nγλ−γτ  log n. Thus condition 3.3 is satisfied.
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– By conditions 2.1 and 2.2, 0 ≤ ν < γ0 < 1/2, thus γτ < −2γ0 < −γ0 − ν.
Thus
p′Logλn,τn
(0+)
p′Logλn,τn
(dn)
= dn/τn + 1 = O(n
−γ0−γτ√log n)  O(nv). Therefore
condition 3.2 is satisfied
– Condition 4.4 is fulfilled by κ(p$, δ) = |p′′Logλn,τn (dn)| = O(n
2γ0+γλ) = o(1)
because γλ < −2γ0.
Proof of Corollary 1
Given dn  ηp:
• For MCPλn,an , :
– Condition 3.3 requires λn > ηp.
– If an is tuned such that dn < anλn, then p
′
$(dn) = λn + dn/an. Ccondi-
tion 3.3 requires λn > ηp so that condition 3.1 cannot be satisfied due to
p′$(dn) > ηp  dn.
– If an is tuned such that dn ≥ anλn, then p′$(dn) = 0. Therefore, condition
3.1 can be satisfied. This restricts the valid range of an: an < dn/λn <
dn/ηp = o(1).
• For SICAλn,τn :
– Condition 3.3 requires p′$(0+) > ηp.
– Note that p′$(dn) of SICA can be expressed as p
′
$(dn) = p
′
$(0+)/(dn/τn +
1)2. Condition 3.1 requires p′$(dn) = p
′
$(0+)/(dn/τn+1)
2  dn. Combin-
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ing condition with 3.3, it leads that ηp/(dn/τn + 1)
2  p′$(0+)/(dn/τn +
1)2  dn. Note that condition 3.2 requires dn/τn →∞ as shown in proof
of proposition 4 so that O(dn/τn + 1) = O(dn/τn). Therefore, the valid
range of τn is restricted as τn < d
3/2
n /η
1/2
p = o(1).
• For Logλn,τn :
– Condition 3.3 requires p′$(0+) > ηp.
– Note that p′$(dn) of Log can be expressed as p
′
$(dn) = p
′
$(0+)/(dn/τn+1).
Condition 3.1 requires p′$(dn) = p
′
$(0+)/(dn/τn + 1)  dn. Combined
with condition 3.3, it leads that ηp/(dn/τn + 1) p′$(0+)/(dn/τn + 1)
dn. Note that condition 3.2 requires dn/τn → ∞ as shown in proof of
proposition 4 so that O(dn/τn+1) = O(dn/τn). Therefore, the valid range
of τn is restricted as τn < d
2
n/ηp = o(1).
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CHAPTER 3: Prediction of cancer drug sensitivity
3.1 Introduction
Human cancer arises from an accumulation of somatic mutations during the life-
time of a patient. Recent studies have shown that cancer growth is often driven by
a few somatic mutations (so-called driver mutations), which may be buried among
a large number of “passenger” mutations [Hanahan and Weinberg, 2011]. Interven-
tions targeting these driver mutations or relevant pathways have proved to be effective
treatment options. However, not all the patients with the targeted somatic lesions
respond to the therapy. Take the targeted breast cancer treatment on the oncogene
HER2 as an example. The HER2 gene encodes a protein product that promotes
the growth of cancer cells. The amplification of the HER2 gene in breast cancer
increases the aggressiveness of the tumor. A drug, Trastuzumab, has been developed
to target HER2 amplification. However, among those breast cancer patients with
HER2 over-expression, only 30% respond to Trastuzumab therapy [De Palma and
Hanahan, 2012]. It is believed that genome-wide genetic heterogeneity among cancer
patients is one of the main reasons for the diverse treatment responses. In other
words, patients with HER2 amplification may have very different genomic features
(e.g., DNA alterations, gene expression, and epigenetic marks) in their genomes, and
these differences may lead to diverse treatment responses.
Preclinical model systems such as cancer cell lines that reflect the genomic diver-
sity of human cancers can be used to identify predictive genomic features/biomarkers
for drug sensitivity [Caponigro and Sellers, 2011]. Recently, two groups (Garnett et al.
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[2012] and Barretina et al. [2012]) have studied drug sensitivity in a large number of
cancer cell lines and measured several types of genomic features including mutations
of cancer genes, genome-wide copy number alterations, and gene expression. The
sample size ranges from 200 to 500 per drug, while the number of genomic features
is greater than 10,000. The authors conducted drug-by-drug analysis to identify as-
sociated genomic features, and they demonstrated that these cell line systems can
capture expected molecular targets of cancer drugs and provide novel findings on the
genomic basis of drug sensitivity.
It is expected that drugs with the same targets may have some common genomic
features in addition to their individual features. The results of the aforementioned
studies [Garnett et al., 2012; Barretina et al., 2012] support this speculation. There-
fore, a joint analysis of the drugs sharing a target may improve the sensitivity and
specificity with which we can identify their shared genomic features. To this end, we
consider the feature selection method for multivariate responses to identify predictive
genomic features of drugs with the same target.
Two types of methods have been developed for feature selection for multivariate
responses: group-wise selection and bi-level selection. Group-wise variable selection
methods, such as group Lasso [Yuan and Lin, 2006] or group adaptive Lasso [Wang
and Leng, 2008], assume that all the response variables within a group are associ-
ated with the same set of covariates [Huang et al., 2012]. This assumption is not
reasonable for cancer drug-sensitivity studies. For example, Garnett et al. [2012]
and Barretina et al. [2012] have shown that drugs with the same target may have
some shared genomic features, but they also have individual features. In contrast,
bi-level selection methods encourage the selection of covariates associated with all
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the response variables, but they also allow some covariates to be associated with one
or a few response variables [Breheny and Huang, 2009]. These flexibilities in bi-level
selection methods are desirable for cancer drug-sensitivity applications. A few meth-
ods have been developed for bi-level selection, such as group bridge [Huang et al.,
2009] and composite MCP [Breheny and Huang, 2009]. Although these methods work
satisfactorily in many real-data analyses, we find that their performance is limited
in some genomic applications where the genomic features have strong correlations.
These issues motivate us to develop a new method to construct predictive models of
cancer drug sensitivity using genomic features.
In this paper, we propose a new bi-level selection method called BipLog. Sim-
ulation studies show that it has substantially higher sensitivity and specificity than
existing methods. We apply BipLog to identify the genomic features associated with
drug sensitivity for two sets of real data [Garnett et al., 2012; Barretina et al., 2012].
We seek to answer a few important questions in our data analysis. First, by splitting
the data from Garnett et al. [2012] into training and testing sets, we assess the vari-
ation in the drug sensitivity that can be explained by our predictive model. Second,
we use all the data from Garnett et al. [2012] to select genomic features associated
with each drug target, and we evaluate their prediction performance using indepen-
dent data from Barretina et al. [2012]. There are substantial differences in these two
studies in terms of the drugs studied and the method to estimate the drug sensitiv-
ity. Therefore, this between-study comparison helps to evaluate the robustness and
generality of our method. Third, we use this between-study comparison to compare
the results of BipLog with those of the “drug-by-drug” analysis using the elastic net
[Zou and Hastie, 2005].
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The remainder of this paper is organized as follows. We introduce BipLog and
its implementation in Section 2. We present the simulation studies and real-data
analyses in Sections 3 and 4. Section 5 provides concluding remarks.
3.2 Method
3.2.1 Objective function
Suppose in a group of n samples, we observe q response variables, denoted yk =
(y1k, ..., ynk)
T (1 ≤ k ≤ q), and p covariates, denoted xj = (x1j, ..., xnj)T (1 ≤ j ≤ p).
We assume that q is much smaller than the sample size n, but p is often larger or much
larger than n. After standardizing yk and xj to have mean 0 and ‖yk‖22 = ‖xj‖22 = 1,
we assume a linear system: E(yk) = Xβk =
∑p
j=1 xjβjk, where Xn×p = (x1, ...,xp)
and βk = (β1k, ..., βpk)
T . Let β = (β1, ..., βq), and denote each row of β by bj =
(βj1, ..., βjq). Let |bj| =
∑q
k=1 |βjk|. The objective function that we aim to minimize
is a penalized least squares:
Q(β) =
1
2n
q∑
k=1
‖yk −Xβk‖22 +
p∑
j=1
q∑
k=1
pθ1 (|βjk|) +
p∑
j=1
pθ2(|bj|), (3.2.1)
where pθ1 (|βjk|) = λ1 log(|βjk| + τ1), pθ2(|bj|) = λ2 log(|bj| + τ2), θ1 = (λ1, τ1), and
θ2 = (λ2, τ2).
In its general form, p$(β) = λ log(|β| + τ) is the Log penalty for a parameter β
with tuning parameters $ = (λ, τ). The Log penalty is a nonconvex penalty, or more
precisely a folded concave penalty [Fan and Lv, 2010] in the sense that it is concave for
β ∈ [0,∞), with continuous derivative p′$(β) ≥ 0, and p′$(0+) > 0. Friedman [2008]
originally proposed the Log penalty in an alternative form: λ log[(1− r)|β|+ r], with
0 < r < 1. Friedman [2008] observed that the Log penalty bridges the L1 penalty
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(Lasso) and the L0 penalty (all-subset selection) as r changes from 1 to 0. To illustrate
the characteristics of the Log penalty, we compare it with one of the most commonly
used penalties, the Lasso penalty (Figure 1). Lasso gives biased penalized estimation
since the penalty increases linearly as the regression coefficients increase. The Log
penalty mitigates this issue by reducing the penalty increase rate for larger regression
coefficients. In a previous study of penalized estimation with a univariate response
variable, we have shown that the Log penalty has better performance than Lasso in
some genomic applications [Sun et al., 2010].
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2
dimensional setting, traditional variable selection methods, such as best subset selection,
are not computationally feasible and are challenging to justify theoretically. Alternative
regularization strategies which utilize penalization to exploit sparsness in the underlying
model are necessary to achieve estimation with reasonable empirical and theoretical per-
formance.
Early work on fi ite dimensional variable selection focused on conv x penalty functions,
like the Lasso (i.e., L1 penalty) (Tibshirani, 1996), to shrink some parameter estimates to
0’s. Adding this penalty to a convex objective function does not change t e convexity of
the obj ctive function and the computations ar straightforward. Finding the minimizer o
t e penalized convex objective function may be accomplished using available algorithms
for convex optimization (Efron et al., 2004; Friedman, Hastie and Tibshirani, 2010). The
theoretical properties of Lasso have been well studied in both finite dimensional (Zou,
2006) and high-dime sional regression problems (Zhao and Yu, 2006; Meinshausen and
Bu¨hlmann, 2006; Zhang and Huang, 2008). Even in finite dimensions, the s lection consis-
tency of Lasso requires an rrepresentability condition on the design matrix (Z ao and Yu,
2006), or equivalently, a neighborhood stability condition (Meinshausen and Bu¨hlmann,
2006). These c nditi ns posit that there are weak correlations between the “importan
covariates” which have non-zero eﬀects and the “unimportan covariates” which have zero
eﬀects. The assumptions may be question ble in high dimensions, for example, in GWAS
studies, where an impor ant SNP may be highly correlated with n arby SNPs.
To address the limitations of convex penalty functions in finite dimensional variable se-
lection, Fa and Li (2001) developed a theoretical framework for non-concave penalized
likelihood based on so-called fold d-concave penalty functions. Let p￿(β) be a function
of x with parameter ￿. A folded-concave penalty p￿(β) is symmetric around 0, and it is
concave in β fo eith r β > 0 r β < 0 p￿￿(β). The popular Smoothly Clipped Absolute
Deviation Penalty (SCAD) (Fan, 1997) was especially developed to have such features.
Recently, other folded-concave penalties have been investigated, including the Minimax
Conc ve Penalty (MCP) (Zhang, 2010)), the Smooth Int gration of Counting and Abso-
lute de iation penalty (SICA) (Lv and Fan, 2009)), and the log penalty (Friedman, 2008;
Sun, Ibrahim and Zou, 2010). It has been theoretically established that in finite dimensions,
penalization methods based on folded-concave penalties provide selection consistent esti-
mates in which zero coeﬃcients are hrunk to zero exactly in finite samples and non-zero
coeﬃcient es imates are asymptotically as eﬃcient as an oracle estimator in which the zero
coeﬃcients are known a priori. These results do not require the irrepresentability condition
for the Lasso. However, they do r ly on the proper selection of a scalar tuning parameter
￿ which controls the shrink ge of the parameter estimators to zero. This theory has been
adapted to high dimensional problems, in which the number of covariates p increases with
the sample size n. In such settings, the theoretical justification requires careful tuning of
the penalty function t balance t e tradeoﬀ between false positives, e.g., zero coeﬃcients
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(a) (b)
Figure 3.1: (a) The Log and Lasso penalty functions. For the Log pe alty, λ =
0.09, τ = 0.225 and for Lasso, λ = 0.4. These two sets of tuning para eters are
comparable in the sense that th y pro i e the s me pen lty derivative at 0+. (b)
The derivatives of thes two penalty functions for the tuning par m ters of Figure
1(a).
We achieved bi-level selection by applying Log penalties to each coefficient and
each group of coefficients (i.e., the coefficients of the same covariate across all re-
sponses) through
∑p
j=1
∑q
k=1 pθ1 (|βjk|) and
∑p
j=1 pθ2(|bj|), respectively. Given that
the observations of the responses and covariates have been standardized, the mag-
nitudes of the regression coefficients are comparable across different responses and
covariates. Here we choose to use a group penalty of the form pθ2(|bj|) = λ2 log(|bj|+
τ2) = λ2 log(
∑q
k=1 |βjk|+τ2). In the following section, we will explain why we use this
group penalty and why an alternative form of the L2 penalty (i.e., λ2 log(‖bj‖2 + τ2)
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where ‖bj‖2 ≡ (
∑q
k=1 β
2
jk)
1/2) does not lead to desirable penalization.
3.2.2 Computation
We estimate the β that minimizes Q(β) in Equation (3.2.1) using a combination
of local linear approximation (LLA) [Zou and Li, 2008] and a coordinate descent al-
gorithm. Specifically, given initial values of β, or the estimates from the tth iteration,
denoted {βˆ(k)j }, we apply LLA to the Log penalty functions pθ1 (|βjk|) and pθ2 (|bj|)
to update them at the (t+ 1)th iteration:
pθ1 (|βjk|) ≈ pθ1
(
|βˆ(k)j |
)
+
∂pθ1 (|βjk|)
∂|βjk|
∣∣∣∣
|βjk|=|βˆ(k)j |
(
|βjk| − |βˆ(k)j |
)
=
λ1|βjk|
|βˆ(k)j |+ τ1
+ C1,
pθ2(|bj|) ≈ pθ2
(
|bˆ(t)j |
)
+
q∑
k=1
∂pθ2 (|bj|)
∂|βjk|
∣∣∣∣
|βjk|=|βˆ(k)j |
(
|βjk| − |βˆ(k)j |
)
=
q∑
k=1
λ2|βjk|
|bˆ(t)j |+ τ2
+ C2,
where C1 and C2 are constants with respect to βjk. Then the objective function at
the (t+ 1)th iteration, denoted Q˜(t+1)(β), can be written
Q˜(t+1)(β) =
1
2n
q∑
k=1
‖yk −Xβk‖22 +
p∑
j=1
q∑
k=1
λ1|βjk|
|βˆ(k)j |+ τ1
+
p∑
j=1
q∑
k=1
λ2|βjk|
|bˆ(t)j |+ τ2
. (3.2.2)
Q˜(t+1)(β) should be understood as a working objective function, which is a function
of the regression coefficients of interest together with estimates of these coefficients at
previous iteration. Therefore, it is different from the objective function Q(β) specified
in Equation (3.2.1). We use a coordinate descent approach to find each regression
coefficient βjk sequentially. To solve for βjk, we minimize the following objective
function
Q˜(βjk) =
1
2
(
βjk − β¯(t)jk
)2
+
{
λ1
|βˆ(k)j |+ τ1
+
λ2∑q
k=1 |βˆ(k)j |+ τ2
}
|βjk|, (3.2.3)
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where β¯
(k)
j = (1/n)
∑n
i=1 xij
(
yik −
∑
l 6=j xilβˆ
(t)
lk
)
. In summary, this “LLA + coor-
dinate descent” algorithm alternates through different iterations indexed by t, and
within each iteration, it estimates all the regression coefficients sequentially. Finally,
this algorithm is considered to have converged if the maximum difference in the co-
efficient estimates between consecutive iterations is less than a predefined threshold,
say 10−4.
The penalty term for each step of the coordinate descent algorithm (Equation (3.2.3))
can be written as an adaptive Lasso form of λ1wˆjk|βjk| where the weight is
wˆjk =
(|βˆ(k)j |+ τ1)−1 + (λ2/λ1)
(
q∑
k=1
|βˆ(k)j |+ τ2
)−1 . (3.2.4)
Therefore, the above computational algorithm is reminiscent of adaptive Lasso [Zou,
2006] rather than adaptive group Lasso [Wang and Leng, 2008], which uses the L2
norm of β as a group-level penalty. In contrast to the adaptive Lasso, which adapts a
weight function 1/|βˆ(k)j |, our weight function in Equation (3.2.4) is a weighted sum of
the contributions of the individual coefficient estimates (|βˆ(k)j |+ τ1)−1 and the group-
level estimates (
∑q
k=1 |βˆ(k)j |+ τ2)−1, with weights 1 and λ2/λ1, respectively. Another
important difference between our penalty and the adaptive Lasso penalty is the in-
clusion of the tuning parameters τ1 and τ2, which prevent an infinite penalty for any
regression coefficient with a previous estimate of 0. This is necessary for the iterative
estimation procedure to proceed with one or more regression coefficients penalized
to 0. The sizes of τ1 and τ2 can be adjusted to apply penalties of the appropriate
strength.
In summary, the penalty terms used in the intermediate steps of our algorithm
(namely in Equations (3.2.2) and (3.2.3)) are different from those of adaptive Lasso
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and adaptive group Lasso. More importantly, they are part of the intermediate ob-
jective function that is updated at each iteration. The ultimate objective function is
that in Equation (3.2.1), with bi-level Log penalties.
3.2.3 A Bayesian interpretation of BipLog
The following Bayesian interpretation provides additional insight into our method
and the role of the tuning parameters. Recall that bj = (βj1, ..., βjq)
T are the regres-
sion coefficients for the jth covariate across the q response variables. Our BipLog
penalty can be derived from a Bayesian setup using the following priors:
p(bj|ωj1, ..., ωjq, ωj) =
{
q∏
k=1
1
2
(ω−1jk + ω
−1
j ) exp
(
−|βjk|
ωjk
)}
exp
(
−
∑q
k=1 |βjk|
ωj
)
,
p(ωjk|δ1, τ1) = inv-Gamma(ωjk; δ1, τ1) = τ
δ1
1
Γ(δ1)
ω−1−δ1jk exp
(
− τ1
ωjk
)
,
p(ωj|δ2, τ2) = inv-Gamma(ωj; δ2, τ2) = τ
δ2
2
Γ(δ2)
ω−1−δ2j exp
(
− τ2
ωj
)
,
where δ1 > 0, δ2 > 0, τ1 > 0, and τ2 > 0 are four hyperparameters. Given the above
specification, after integrating out ωjk and ωj, we obtain the density of bj:
f(bj|δ1, τ1, δ2, τ2) ∝ τ
δ2
2 δ2
2(
∑q
i=1 |βjk|+ τ2)1+δ2
q∏
i=1
τ δ11 δ1
2(|βjk|+ τ1)1+δ1 . (3.2.5)
This Bayesian interpretation illustrates the similarities and differences of our
method and adaptive Lasso. The priors for bj include the Laplace prior for each
regression coefficient βjk and the Laplace prior for the L1 norm of bj. The Laplace
prior corresponds to the Lasso penalty [Tibshirani, 1996; Park and Casella, 2008].
The fact that we assign different parameters ωjk and ωj for the Laplace priors of the
regression coefficients βjk and |bj| implies that these priors correspond to adaptive
Lasso penalties. In the high-dimensional setting where the number of covariates p
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is much larger than n, one cannot obtain a good initial estimate of each regression
coefficient to decide the prior distribution of βjk. Therefore, we further assign prior
distributions for ωjk and ωj, and after integrating out ωjk and ωj, we obtain the
density of bj (Equation (3.2.5)) in terms of the hyperparameters δ1 > 0, δ2 > 0,
τ1 > 0, and τ2 > 0. This density of bj is connected to the Log penalty. In fact,
− log{f(bj|δ1, τ1, δ2, τ2)} gives exactly the same form of the BipLog penalty as in
Equation (3.2.1) if we set nλ1 = 1 + δ1 and nλ2 = 1 + δ2. This also gives more
insight into the scale of the tuning parameters of λ1 and λ2. Empirically, the grids
of possible values of λ1 and λ2 could be set at the scale of n
−1 since both δ1 and δ2
are constant O(1).
3.2.4 A penalized maximum likelihood estimation perspective
A generalized form of PMLE is:
n−1ln(β)− ρ(β),
where ln(β) is the log-likelihood function and ρ(.) is a general form of the penalty
function. The goal of PMLE is to select the important variables for which the penal-
ized coefficient estimates are nonzero [Fan and Lv, 2010].
If we assume that the q response variables follow a multivariate Gaussian distribu-
tion, the penalized least squares estimation problem addressed in this paper is closely
related to the PMLE. The difference is that in the PMLE estimation, we also need to
estimate the inverse covariance matrix of the q response variables given the covariates,
and the strength of the penalization is related to not only the tuning parameters but
also the residual variance. A smaller residual variance leads to a smaller penalization.
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This is reasonable since a smaller residual variance means a better model fitting, and
thus it deserves less penalization. However, in a high-dimensional setting, where p is
larger or much larger than n, the relationship between the residual variance and the
penalization strength may introduce instability into the iterative updating algorithm.
During the iterations, if several covariates are mistakenly included in the model be-
cause of their spurious correlations with the residual errors, the residual variance will
become smaller, which further attenuates the penalty strength. This then encourages
the selection of more covariates and may lead to overfitting problems. We have ob-
served this type of overfitting for PMLE in our preliminary work. Therefore, although
PMLE is expected to be more efficient than penalized least squares estimation, we
choose to use the latter since it is more robust.
3.2.5 Tuning parameter selection
We choose the best set of tuning parameters by a grid search over an initial pool of
parameters. Based on the Bayesian interpretation of BipLog, we set λ1 = (1 + δ1)/n
and λ2 = (1 + δ2)/n. The initial values for δ1 and δ2 range from 0 to 5.0 with a
0.5 increment. Let βˆmlsji denote the estimates of the marginal regression coefficients.
The initial values for τ1 and τ2 are from 1
−3 to maxj,k{|βˆmlsjk |} and from 1−3 to
maxj{
∑q
k=1 |βˆmlsjk |}, respectively, in predefined numbers. We select a combination of
tuning parameters using the extended BIC [Chen and Chen, 2008]. The extended
BIC for a model m is:
BIC%(m) = −2 log ln{θˆ(m)}+ κm log n+ 2% log ς(Sκm),
where ln{θˆ(m)} is the log likelihood, θˆ(m) are estimates of all the parameters, κm
is the degree of freedom for model m, and ς(Sκm) is the number of models with
degree of freedom equal to κm. Specifically, ln{θˆ(m)} is calculated using the pe-
nalized coefficient estimates assuming a multivariate Gaussian distribution. Given
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the coefficient estimates, we can calculate the determinant of the residual covariance
matrix, denoted |Σˆ|, and then the log likelihood is simply −(1/2) log |Σˆ|. Note that
the calculation of |Σˆ| is straightforward because of our assumption that the number
of response variables is much smaller than the sample size n. We set the number of
nonzero coefficient estimates to κm and ς(Sκm) =
(
pq
κm
)
, i.e., the number of choices of
κm coefficients from a total of pq regression coefficients. In addition, following Chen
and Chen [2008], we set % ≈ 1− 1/[2log(pq)/log n].
3.3 Simulation Studies
3.3.1 Simulation setup
We used simulated data to evaluate our method and two existing methods for
bi-level variable selection. The major challenges of feature selection using genomic
data are the high dimensionality and the correlations among the genomic features.
It is difficult to simulate high-dimensional genomic data with a realistic correlation
structure except in a few special cases. One such case is the correlation structure
among SNPs (single nucleotide polymorphisms) in an F2 cross. The R package qtl
provides a set of utility functions for such simulations [Broman et al., 2003]. Using
the function sim.map in R/qtl, we first simulated a genetic marker map of 2,000
SNPs from 20 chromosomes of length 90 cM, with 100 SNPs per chromosome. Then
we used the function sim.cross in R/qtl to simulate the genotype data of an F2
cross with sample size n = 200 based on the simulated marker map. As expected, the
simulated genotypes show strong correlations for nearby SNPs (average R2 is 0.96
for SNPs within 1 cM) and no correlation for SNPs from different chromosomes. We
randomly selected p = 600 SNPs from the 2,000 SNPs for the following simulation of
quantitative traits.
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We simulated a total of q = 30 quantitative traits from the multivariate linear
model
Yn×q = Xn×pβp×q + En×q, (3.3.1)
where Y = (y1, ..., yq). The residuals E were simulated from a multivariate Gaussian
distribution with mean 0 and compound symmetry covariance structure with diago-
nal variance (0.25+0.5) and off-diagonal covariance 0.5. Traits 1 to 10 share a pair of
causal SNPs, and each has its own causal SNP. Traits 11 to 30 do not have individual
causal SNPs. Traits 11 to 20 share two pairs of causal SNPs, and traits 21 to 30
share one pair of causal SNPs. The pairs of causal SNPs shared across traits may be
located in different chromosomes (unlinked) or at the same chromosome with the ef-
fect sizes being (η, η) (SNPs linked in coupling) or (η, -η) (SNPs linked in repulsion).
We set the genotype effect size η = 0.3 or 0.6. Given the three relationships between
the causal SNP pairs and the two effect sizes, there are six simulation scenarios in
total.
We compared BipLog with group bridge and composite MCP [Huang et al., 2012].
We used the implementation of group bridge and composite MCP inR/grpreg, with
the default choice of 100 possible values of the tuning parameter λ, which were uni-
formly distributed on a log scale. We used an oracle criterion to select the tuning
parameters to avoid confounding the feature-selection performance with the crite-
rion for the tuning-parameter selection. Specifically, let s be the number of causal
SNPs, and let D be the number of discoveries, i.e., the number of nonzero regression
coefficient estimates. D = TD + FD, where TD and FD are the number of true and
false discoveries. Under nonnull simulations, the oracle criterion evaluates a model
based on three measures: the false discovery rate FD/D, the power TD/s, and the sum
of the squared errors of the regression coefficient estimates
∑p
j=1
∑q
k=1 |βˆjk − β˜jk|2,
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where β˜jk is the true value of βjk. We select the model with the smallest value of
wt(FD/D−TD/s)+∑pj=1∑qk=1 |βˆjk− β˜jk|2, where wt is a weight to balance the number
of true/false discoveries and the bias. We set wt to 10 so that we select the models
mainly based on (FD/D−TD/s), and the sum of squared errors is a secondary criterion.
We also set wt = 1 or 0.1 for comparison purposes, and the conclusions are consistent
with the results for wt = 10 (results not shown).
Table 3.1 summarizes the empirical performance of the three bi-level selection
methods: BipLog, group bridge (gBridge), and composite MCP (cMCP). When the
shared SNPs are unlinked or linked in coupling, the three methods have a comparable
number of true discoveries while BipLog has many fewer false discoveries. When the
shared SNPs are linked in repulsion and the effect size is relatively small (η = 0.3),
gBridge and cMCP fail to identify most of the true discoveries while BipLog finds
almost 50% of them. In general, BipLog can identify true signals with a smaller bias
in the coefficient estimates.
3.4 Genomic signatures of cancer drug sensitivity
For a panel of 639 human cancer cell lines, Garnett et al. [2012] measured the mu-
tation statuses of 64 commonly mutated cancer genes (exon-sequencing), the genome-
wide copy number alterations (Affymetrix SNP array 6.0), and the gene expression
(Affymetrix HT-U133A microarray). A total of 130 drugs, including those for tar-
geted cancer therapy or broad-spectrum chemotherapy, were selected for the analysis.
Each drug was studied in a range of 275 to 505 cell lines. For a panel of 947 hu-
man cell lines, Barretina et al. [2012] measured the mutation statuses of 1600 genes
(targeted-sequencing), the genome-wide copy number alterations (Affymetrix SNP
array 6.0), and the gene expression (Affymetrix U133 plus 2.0 array). Twenty-four
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Table 3.1: Comparisons of three bi-level selection methods (group bridge (gBridge),
composite MCP (cMCP), and BipLog) via simulation studies. For each of the 6
simulation scenarios, 30 traits are considered. The total number of true trait-SNP
associations is 90, which includes 10 associations due to SNPs affecting only one
trait (individual SNPs) and 80 associations due to SNP pairs shared across traits
(shared SNPs). The tuning parameters are selected to minimize 10(FD/D−TD/s) +∑p
j=1
∑q
k=1 |βˆjk−βjk|2. We present the median number of true discoveries (TD) and
false discoveries (FD) and the average bias of the regression coefficient estimates (in
brackets []) for the true signals over 100 simulations.
gBridge cMCP BipLog
Shared SNPs are unlinked
η = 0.3
individual-SNPs:TD [bias] 9 [0.14] 9 [0.20] 7 [0.10]
shared-SNPs:TD [bias] 72 [0.16] 68 [0.20] 80 [0.076]
total FD 172 39 3
η = 0.6
individual-SNPs:TD [bias] 10 [0.26] 10 [0.29] 10 [0.071]
shared-SNPs:TD [bias] 78 [0.29] 80 [0.30] 80 [0.059]
total FD 117 11 0
Shared SNPs are linked in coupling
η = 0.3
individual-SNPs:TD [bias] 1 [0.15] 8 [0.21] 7 [0.10]
shared-SNPs:TD [bias] 72 [0.15] 69 [0.14] 77 [0.082]
total FD 60 17 4
η = 0.6
individual-SNPs:TD [bias] 1 [0.30] 10 [0.31] 10 [0.086]
shared-SNPs:TD [bias] 77 [0.27] 80 [0.18] 80 [0.075]
total FD 44 3 1
Shared SNPs are linked in repulsion
η = 0.3
individual-SNPs:TD [bias] 2 [0.14] 6 [0.24] 7 [0.061]
shared-SNPs:TD [bias] 0 [0.13] 0 [0.28] 36 [0.12]
total FD 1 1 7
η = 0.6
individual-SNPs:TD [bias] 10 [0.21] 10 [0.19] 10 [0.077]
shared-SNPs:TD [bias] 72 [0.28] 69 [0.46] 80 [0.14]
total FD 127 87 4
anticancer drugs were screened for 500 cell lines on average. In both studies, the drug
sensitivity was assessed by IC50, which is half-maximal inhibitory concentration.
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3.4.1 Evaluation of prediction model using training/testing data
Of the 130 drugs analyzed by Garnett et al. [2012], 41 have non-missing IC50
values in fewer than 331 cell lines, while the other 89 drugs have non-missing IC50
values in more than 561 cell lines. These 89 drugs were grouped by their targets, and
two drugs were excluded from our analysis because they do not group with any other
drugs. We will first study these 87 drugs since a larger sample size is necessary for
the following studies using training/testing sets.
Of the 87 drugs, 57, 69, and 56 are grouped by targeted family, targeted process,
and targeted molecule, respectively. One drug is often grouped in multiple ways.
There are four targeted families: chemotherapy, CTK (cytoplasmic/non-receptor ty-
rosine kinase), RTK (receptor tyrosine kinase), and S/T Kinase (serine/threonine
protein kinase), which include 12, 7, 10, and 30 drugs respectively. There are 18
targeted processes and 24 targeted molecules groups. Most groups based on the tar-
geted processes have fewer than 10 drugs, and the two largest groups have 17 and
20 drugs, respectively. For the targeted molecules, most of the groups have fewer
than 5 drugs, and the largest group has 7 drugs. The three grouping strategies have
a semi-hierarchical order: targeted family > targeted process > targeted molecule.
For example, the group for the RTK targeted family includes the groups for targeted
processes such as ERK Signaling and PI3K/MTOR. Furthermore, the ERK signaling
targeted process includes targeted molecules such as EGFR and MET.
To evaluate the validity of the selected features, we split the cell lines into training
and testing sets. For the testing set, we randomly selected 65 cell lines from those
with non-missing IC50 values for all 87 drugs. We used the remaining cell lines as the
61
training set. Both the training and testing data were standardized to have a mean of
0 and a standard deviation of 1 for the response and covariates. The training data
were then used for feature selection. If a drug belonged to more than one group, we
took the union of the genomic features associated with that drug across the groups.
Given the genomic features selected for each drug, we re-estimated the regression
coefficients using the training data (denoted βˆtrain) and thus obtained a predictive
model for each drug. Next, we used the testing data to estimate the percentage of
the variance explained by the predictive model. Let SSz be the sum of squares of
z, and let ytest and Xtest be the standardized log(IC50) and genomic features in the
testing set. Then
Prediction R-square ≡ 1− SStest
SSytest
, where test = ytest −Xtestβˆtrain.
The possible range for prediction R-square is (−∞, 1]. A negative value clearly indi-
cates a bad prediction, and the significance of a positive value was evaluated by the
following approach. Given a drug with k associated features, we randomly chose k
features from the candidate 13,847 features including 84 binary variables of cancer
gene mutation statuses, 426 copy number alterations, 13,321 gene expressions, and 16
binary variables for cancer types, under the null scenario where these k features are
irrelevant to the drug sensitivity. We estimated their regression coefficients using the
training data, and then evaluated the prediction R-square using the testing data. We
constructed the null distribution of the prediction R-square by repeating the above
procedure 1,000 times, and then we calculated the p-value as the percentage of the
null simulations where the prediction R-squares were greater than or equal to the
observed prediction R-square. This approach is computationally efficient: it took 8
seconds on average to generate the p-value for each drug.
BipLog identified that 70 of the 87 drugs were associated with at least one ge-
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nomic feature. Figures 3.2a and 3.2b show the distributions of the number of selected
features and the prediction R-squares across these 70 drugs. Forty-nine (70%) of the
70 drugs had prediction R-squares greater than 0, and 17 (24%) had prediction R-
squares greater than 20%. Forty-one of the drugs had significant prediction R-squares
at the 0.05 significance level (Figure 3.2c), which corresponds to an estimate of FDR
= 87× 0.05/41 ≈ 0.1. As expected, there is a strong correlation between the predic-
tion R-squares and their p-values, although the relationship is not monotonic (Figure
3.2d). Therefore, in practice it is helpful to consider both the size of the prediction
R-square and its p-values. Overall, these results suggest that the identified genomic
features could provide useful predictions of drug sensitivity. We will give specific
examples in the next subsection.
3.4.2 Construction of prediction model
Next, we combined the training and testing sets and selected the genomic features
using all the available data for the 87 drugs. A feature was selected by a group if it
had a nonzero coefficient for at least one drug in the group. For the drugs grouped by
target family, we selected 10, 4, 6, and 0 features for the groups Chemotherapy, RTK,
CTK, and S/T Kinase, respectively. Figure 4.2 shows the distribution of the number
of features selected per group for the targeted processes and targeted molecules.
Next we discuss a few examples, shown in Figure 3.4; the complete results can be
found in the supplementary materials. Somatic mutations may lead to the fusion of
two genes. The abnormal gene BCR-ABL is formed by the fusion of genes BCR and
ABL; this is often observed in chronic myeloid leukemia (CML). BCR-ABL encodes
a tyrosine kinase that is not regulated by cellular signals and thus causes unregulated
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Figure 3.2: Summary of the genomic feature selection results of the within-study
analysis. (a) Distribution of the number of genomic features selected per drug. (b)
Distribution of the prediction R-squares for each drug. (c) Distribution of the p-
values of the prediction R-squares. (d) Scatter plot of the prediction R-squares and
their corresponding p-values. Since the null distribution was simulated as 1000 null
samples, the smallest p-value is 0.001.
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Figure 3.3: Distribution of the number of selected features by the two grouping
strategies.
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B. MEK1/MEK2
D. Mitosis
1
Groupwise_mitosis.xls
Vinorelbine EpothiloneB Vinblastine Docetaxel BX-795 SL0101-1 BI-D1870 ZM-447439 RO-3306
ABCB1 0.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
YAP1 0.00 0.00 -0.25 -0.24 0.00 0.00 -0.10 0.00 0.00
AXL 0.00 -0.13 0.00 -0.17 -0.36 0.00 0.00 -0.19 -0.15
blood 0.00 0.00 0.00 0.28 0.18 0.00 0.33 0.21 0.15
1
Groupwise_MEK1.2.xls
RDEA119 CI-1040 PD-0325901 AZD6244
PHLDA1 -0.49 -0.39 -0.43 -0.36
A. BCR_ABL 
1
Groupwise_ABL.xls
AP-24534 Nilotinib Bosutinib
EGFR 0.00 0.00 -0.19
AZU1 -0.20 0.00 0.00
CAV2 0.00 0.00 -0.19
BCR_ABL_MUT -0.39 -0.67 0.00
C. ERBB2
C1ORF116 Lapatinib ERBB2 -0.30713692
CYR61 Lapatinib ERBB2 -0.34903966
ERBB2 MUT Lapatinib ERBB2 -0.31306867
C1ORF116 BIBW2992 ERBB2 -0.36339611
STAM2 BIBW2992 ERBB2 -0.15896628
ERBB2 CN BIBW2992 ERBB2 -0.25649148
Lapatinib BIBW2992
C1ORF116 -0.31 -0.36
CYR61 -0.35 0.00
ERBB2_CN 0.00 -0.26
ERBB2_MUT -0.31 0.00
STAM2 0.00 -0.16
Figure 3.4: Genomic features associated with four groups of drugs that share the
molecular targets BCR ABL (A), MEK1/MEK2 (B), ERBB2 (C) or the process
target Mitosis (D). For each group, the regression coefficient matrix is shown for
those genomic features with at least one nonzero coefficient, where a row corresponds
to a genomic feature and a column corresponds to a drug. The feature X MUT is
a binary indicator showing whether or not gene X has mutation; ERBB2 CN is the
copy number of the gene ERBB2; blood is a binary indicator showing whether or
not the cell line is derived from a blood tumor. The remaining features are gene
expressions.
cell proliferation, which may lead to cancer. Three drugs that target BCR-ABL pro-
tein products are included in this study (Figure 3.4A). The sensitivity of two of these
drugs is negatively correlated with the occurrence of the BCR-ABL mutation, which
is expected. The negative correlation indicates that the presence of the BCR-ABL
mutation is related to a reduction in log(IC50), hence an increase in the drug sensi-
tivity. There are two interesting new findings in this example. (1) The sensitivity
of AP-24534 also increases as the expression of AZU1 increases, which is consistent
with the tumor suppressor role of AZU1 [Chen et al., 2000]. (2) The sensitivity of
Bosutinib is associated with the expression of two cancer-related genes, EGFR and
CAV2, instead of the BCR-ABL mutation. EGFR is a signaling protein that plays an
important role in many types of cancer, and CAV2 is potentially a tumor suppressor
[Lee et al., 2011].
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Figure 3.4B shows that when the gene encoding PHLDA1 has a higher expression,
all four drugs that target MEK1/MEK2 (mitogen-activated protein (MAP) kinase)
have higher sensitivity. Several previous studies have suggested that PHLDA1 may
be functionally important in cancer, and some studies have shown that it functions
in the MEK1/MEK2 pathway [Oberst et al., 2008]. This finding suggests that the
expression of PHLDA1 could be an informative biomarker for the efficacy of cancer
drugs targeting MEK1/MEK2.
The ERBB2 (also known as the HER2) gene encodes a protein product that
promotes the growth of cancer cells. The amplification of the ERBB2 gene in breast
cancer increases the aggressiveness of the tumor. Our analysis identifies several genes
related to the two drugs targeting ERBB2 (Figure 3.4C): BIBW2992 and Lapatinib.
BIBW2992 has been approved by the U.S. Food and Drug Administration for use
against non-small cell lung carcinoma (NSCLC), and its efficacy for breast cancer
treatment is being evaluated. Lapatinib has been approved for treatment in ad-
vanced HER2-receptor-positive breast cancer patients. As expected, we identified
the ERBB2 mutation or the ERBB2 copy number variation as genomic features
associated with these drugs. The novel findings are the association with the gene
expressions of C1ORF116, CYR61, and STAM2. C1ORF116 interacts with SMD2
and SMD3, which are both closely related to growth-factor signaling and tumorige-
nesis [Tian et al., 2003]. Several studies have shown that CYR61 is involved with
breast cancer tumorigenesis and progression [Tsai et al., 2002; Planque and Perbal,
2003]. Furthermore, the gene expression CYR61 has been found to be associated
with stage, tumor size, and estrogen receptor expression in breast cancer patients
[Xie et al., 2001]. In addition, STAM2 may be involved in “signaling by EGFR in
cancer” [Croft et al., 2011]. Therefore, the combined information from the ERBB2
mutation (or copy number alterations) and gene expression of C1ORF116, CYR61,
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and STAM2 may provide a more accurate prediction of drug efficacy than the ERBB2
mutation/copy number alteration alone.
Figure 3.4D presents the estimated coefficient matrix for nine drugs that target
the Mitosis process. The features shared by several drugs include the expression of
genes YAP1 and AXL and the blood-tissue indicator. YAP1 encodes “YES-associated
protein 1,” which has been shown to be related to different types of cancer [Wang
et al., 2012; Rosenbluh et al., 2012]. AXL encodes a receptor tyrosine kinase, which
is also involved with tumorigenesis [Hong et al., 2013]. Previous studies have shown
that the protein products of YAP1 and AXL may function together [Cui et al., 2011].
3.4.3 Validation of the prediction model
We treated the data of Garnett et al. [2012] and Barretina et al. [2012] as the
training and testing study data, respectively, constructed the prediction models from
the training data, and then evaluated them using the testing data. Of the 24 drugs
analyzed by Barretina et al. [2012], 12 were analyzed in the training study. Five of
the 12 drugs had missing values in more than 325 cell lines in the training study, so
they were not included in the 87 drugs in the above analysis. To address this issue, we
conducted another group-wise analysis using the training data for groups involving
any of these 12 drugs. Then we chose the features associated with each drug as the
union of the features selected in this new analysis and those from the above analysis,
whenever possible. For the 12 drugs that were analyzed using the testing data but
not the training data, we fitted the prediction models using the features selected for
their drug targets. For example, for the drug Topotecan, which targets the molecule
TOP1, we used the features from the training study associated with the drug group
that targeted TOP1 as the features associated with Topotecan.
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To determine whether at least one of the selected features is associated with drug
sensitivity in the testing data, we used an F-test to compare the intercept-only model
and the model with all the identified genomic features. The analysis results are pre-
sented in Figure 3.5. The F-test p-values are smaller than 0.05 in most cases (note
that only drugs with at least one identified genomic feature are included in the fig-
ure). The drugs PLX4720 and Lapatinib are particularly significant, with p-values
of 10−39 and 10−17 respectively.
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Figure 3.5: Evaluation of the predictive model in the study of Barretina et al. [2012];
the models themselves were constructed using the data of Garnett et al. [2012]. The
“validated drugs” are the drugs that were analyzed in both studies. The inferred
drugs are the drugs that were analyzed only in the study of Barretina et al. [2012]. The
x-axis shows the drug targets, and the y-axis shows the − log 10(p-values) from the F-
test that compares the model with all the identified genomic features to the intercept-
only model using the data of Barretina et al. [2012]. The numbers in brackets are
the number of features in the corresponding prediction model.
To compare the genomic features identified by our method and the elastic net
analysis in the study of Garnett et al. [2012], we calculated the prediction R-square
of log(IC50) in the testing study for the 12 drugs that were analyzed in both the
training and testing studies. Because of the disparate ranges and scales of log(IC50)
in the two studies, as shown in Figure 3.6, we could not directly use the regression
coefficients estimated from the data of Garnett et al. [2012]. Instead, we used the
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following procedure to estimate the prediction R-squares. First, for each drug, we
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Figure 3.6: Pairwise box-plots of logIC50 for the 12 drugs that were analyzed in both
Barretina et al. [2012] and Garnett et al. [2012]. For each drug, the blue box-plot
corresponds to the study of Barretina et al. [2012], and the transparent box-plot
corresponds to the study of Garnett et al. [2012].
randomly split the cell lines in the testing data into two groups of equal size, and
denoted them set1 and set2. We used the cell lines of set1 to estimate the linear
regression coefficients of the features identified by the training data. Then we used
set2 to estimate the prediction R-square. We repeated this procedure 100 times to
obtain median prediction R-squares as our final estimates. Then we applied Monte
Carlo simulations to evaluate the significance of the prediction R-squares, similarly
to our approach in Section 4.1.
Of the 12 drugs, 6 had a prediction R-square greater than 0 using a set of features
selected by our method or the elastic net analysis in the training study. The results
for these 6 drugs are presented in Table 3.2. In general, BipLog tended to choose
more parsimonious models than those chosen by the elastic net, and the estimates
of the prediction R-square were statistically significant in all but one case. Some of
the models selected by the elastic net had greater prediction R-squares than those
from BipLog, such as AZD6244 and PLX4720. However, because more variables were
included in the model, they were not significantly larger than what was expected from
69
the null distributions.
Table 3.2: Prediction R-squares in the study of Barretina et al. [2012].
Groupwise analysis by BipLog
Drug 17-AAG AZD6244 PD-0325901 PLX4720 Erlotinib Lapatinib
Prediction R2 [Num of X] 15% [5] 2.5% [1] 7.3% [1] 27% [3] < 0.0% [2] 21% [5]
p-value < 0.001 < 0.001 < 0.001 < 0.001 1.00 < 0.001
Drug-by-drug analysis by Elastic Net
Drug 17-AAG AZD6244 PD-0325901 PLX4720 Erlotinib Lapatinib
Prediction R2 [Num of X] 15% [16] 10% [7] 29% [17] 29% [5] 1.5% [7] 14% [16]
p-value < 0.001 0.275 < 0.001 0.525 0.949 0.430
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CHAPTER 4: Models that are subject to unidentifiable parameters.
4.1 Introduction.
In this paper, we consider an estimation problem where a certain parameter values
such as β = 0 will cause an identifiability issue. Similar problem has been addressed
in the hypothesis testing framework, where a nuisance parameter ζ is present only
under the alternative hypothesis (β 6= 0). Therefore, the nuisance parameter is not
identifiable under the null hypothesis (β = 0). It is a non-regular testing frame-
work since the nuisance parameter only present under the alternative hypothesis.
Therefore, the standard large sample asymptotic theory cannot be directly applica-
ble (Davtes [1977], Davies [1987]).
For the estimation problems of change points, there are extensive literatures. For
instance, Bai [1997] establishes the convergence rate and asymptotic distribution for
the least square estimation of a change point in multiple regression. Muggeo [2003]
considers the regression models with one or more break-points parameters and utilizes
a linearization technique for fitting piecewise terms in the models. He and Severini
[2010] studies the theoretical properties of maximum likelihood estimators of the pa-
rameters of a multiple change-point model.
In the maximum likelihood estimation framework, due to the unidentifiable pa-
rameter (ζ) issue under null hypothesis (β = 0), the maximum likelihood estimator
(MLE) have regular properties only if the likelihood function is specified correctly
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with respect to the parameter value of β. Specifically, when β = 0, the parameters
ζ and β should be both absent from the likelihood function; then the MLE for the
rest parameters are regular. On the contrary, when β 6= 0, the parameters ζ and β
are both present in the likelihood function; the MLE for all parameters are regular
as well. Unlike the methods for estimation of the change points, we are interested in
designing an estimation procedure which can automatically take care of the specifi-
cation of correct likelihood function with respect to β = 0 or β 6= 0.
Since whether β equals to 0 plays a key role in determining the form of likeli-
hood function, we utilize the idea of penalization estimation procedure and apply
adaptive Lasso penalty to β. The adaptive Lasso penalty incorporated to β has the
form: λ|β|w, where λ is a tuning parameter, and w stands for the adaptive weight
associated to β. As shown in [Zou, 2006], given a proper chosen w, adaptive lasso
performs as well as if the true underlying likelihood were given in advance.
To choose a proper weight for β, we apply the idea of constructing a test statistics
in (Davtes [1977], Davies [1987]), where the author considers a test statistic, which
is a function of the nuisance parameter ζ. If ζ is unknown, the test statistics takes
supremum over a range of possible values of ζ. For large values of test statistic, the
null hypothesis (β = 0) will be rejected. Similarly, we take the supremum of profile
likelihood estimates of βˆ(ζ) over a range of possible values of ζ to be the weight for
β. The weight shares similar properties of the test statistic. For large values of the
weight, the true value of β is more likely to be non-zero.
The paper is organized as following. In the section 2, we present the asymptotic
results for our penalized estimation procedure. Section 3 shows the simulation study
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and section 4 presents a real data analysis.
4.2 Asymptotic results.
4.2.1 Notations
Let Y represent a random sample (y1, ...yn) of observations and each yi, i = 1, ..., n
is independently and identically distributed with density {f(yi; θ, ζ) : θ ∈ Θ, ζ ∈ Ξ}
with respect to some σ-finite measure µ. The parameter spaces Θ and Ξ are assumed
to be a compact subset of metric spaces Rs and R1 respectively. The parameter
θ takes the form θ = (β′, γ′)′, and β ∈ B, γ ∈ Γ,Θ = B × Γ , where B ∈ R1, and
Γ ∈ Rs−1. The likelihood function is L(n)(θ, ζ) = Πni=1f(yi; θ, ζ) and the log-likelihood
function is l (n)(θ, ζ) =
∑n
i=1 log f(yi; θ, ζ). Note that given that β ∈ B0 = 0, the
parameter ζ is absent from the likelihood function so that it renders ζ to be uniden-
tifiable, i.e. the densities are equivalent to all values of ζ at fixed values γ and β = 0.
Let Θ0 = B0 × Γ, and let θ0 denote the θ ∈ Θ0. In this case, since β is realized at 0,
the density f(yi; θ0, ζ) is independent of ζ and let f0(yi; γ) denote this special class
density. The corresponding likelihood function is given by L(n)0 (γ) = Πni=1f0(yi; γ) and
l
(n)
0 (γ) =
∑n
i=1 log f(yi; γ). On the other hand, given that β ∈ Bc0, θ ∈ Bc0 × Γ = Θ1,
and ζ ∈ Ξ, all parameters (θ, ζ) are identifiable.
Additionally, let l˙ (n)(θ; ζ) be the s-vector of partial derivatives of l (n)(θ, ζ) with
respect to θ, and l¨ (n)(θ; ζ) be the s×s matrix of second partial derivatives of l (n)(θ, ζ)
with respect to θ. Note that l˙ (n)(θ; ζ)|θ=θ0 and l¨ (n)(θ; ζ)|θ=θ0 depend on ζ in general
even though l (n)(θ, ζ)|θ=θ0 and L(n)(θ, ζ)|θ=θ0 do not [Andrews and Ploberger, 1995].
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4.2.2 The estimation procedure
To address the non-identifiability issues for θ ∈ Θ0 in parameter estimation,
we apply the idea of penalized estimation with adaptive Lasso penalty [Zou, 2006].
Specifically, we consider the penalized log-likelihood function
Q(n)(θ; ζ) = l (n)(θ; ζ)− λnwˆn|β| − λnn−1/2I(β = 0)|ζ|, (4.2.1)
where λn > 0 is a tuning parameter, and the weight wˆn = |βˆ∗|−τ for some τ > 0,
βˆ∗ is supζ∈Ξ βˆ(ζ), the supremum over the profiled maximum likelihood estimator of
L(n)(θ; ζ) at any ζ ∈ Ξ. βˆ(ζ) is the element in θˆ(ζ) = (βˆ(ζ), γˆ(ζ)), which satisfies
l (n)(θˆ(ζ); ζ) = supθ∈Θ l
(n)(θ; ζ) ∀ζ ∈ Ξ with probability to 1 for θ ∈ Θ.
Next, we study the theoretical properties of the penalized estimator of (4.2.1)
when the underlying true model is either (β = 0; unidentifiable ζ) or (β 6= 0; identifi-
able (θ, ζ)). The weight wˆn is the key in dealing with the non-identifiability issue for
θ ∈ Θ0. First, we give the assumption 1 for the weight of β to ensure the desirable
properties of the penalized estimator under the potential identifiability issue.
Assumption 1.
1.1 Given the likelihood function with θ ∈ Θ0, where β = 0, supζ∈Ξ |βˆ(ζ)− 0| →p 0
as n goes to ∞ with rate nα, where α > 0.
1.2 Given the true distribution with parameter θ ∈ Θ1, where β 6= 0, supζ∈Ξ |βˆ(ζ)| →p
cβ as n goes to ∞, where cβ is some nonzero constant.
Similar to [Andrews and Ploberger, 1995], we assume the parametric model is suf-
ficiently regular such that the MLE θˆ(ζ) is consistent for θ ∈ Θ0 uniformly over ζ ∈ Ξ
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for the above Assumption 1.1. Assumption 1.2 holds for any regular likelihood func-
tion since supζ∈Ξ |βˆ(ζ)| covers the maximum likelihood estimator at the true value of
ζ, which is consistent for the true parameter non-zero β. Under the assumption 1,
when β = 0, the weight inflates to infinity as the sample size grows, this induces the
estimator of β to be penalized to zero. Once the estimator of β is penalized to be 0,
the realized equation (4.2.1) is equivalent to l
(n)
0 (γ), and the penalized estimator of
γ is equivalent to the maximum likelihood estimator of l
(n)
0 (γ).
For the following theoretical discussion, we first consider the case where
(β = 0; unidentifiable ζ), if Assumption 1 and Assumption 2 (presented in the Ap-
pendix) are hold, we will show that the penalized estimator is equivalent to the MLE
of the likelihood function L(n)0 (γ) = Πni=1f0(yi; γ). Next, for the case where (iden-
tifiable (θ, ζ)), if Assumptions 1 and 3 (presented in the Appendix) are hold and
without assuming the differentiability of likelihood function with respect to ζ, we
will show that the penalized estimator is consistent. In addition, if the likelihood
function is differentiable with respect to ζ, we provide a standard argument for the
convergence rate and asymptotic normality of the penalized estimator. For the case
where the likelihood function it not differentiable with respect to ζ, we consider the
change-point model as an example, and provide specialized arguments for it.
4.2.3 Model of (β = 0; unidentifiable ζ)
We establish that if β = 0, then the penalized estimation procedure is equivalent
to the maximum likelihood estimation for the true likelihood L(n)0 (θ0) with probability
going to one asymptotically in the following Theorem 1. In other words, the estimator
of the non-zero parameters γ is asymptotically equivalent to the maximum likelihood
estimator for L(n)0 (θ0). Its proof can be found in the Appendix.
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Theorem 1. Given θ ∈ Θ0, and under the assumptions 1 and 2 (presented in
the Appendix) for the likelihood function, if λnn
−1/2 → 0 and λnn(2ατ−1)/2 → ∞,
then with probability to 1, there exists a maximizer (θ˜(n), ζ˜(n)) of Q(n)(θ, ζ) such that
P (β˜(n) = 0)→ 1 as n→∞. In addition, ‖γ˜−γ0‖ = Op(n−1/2) with
√
n(γ˜(n)−γ0)→d
N(0, I(γ0)
−1), where I(γ0) is the Fisher information matrix corresponding to L(n)0 (θ0).
4.2.4 Model of (β 6= 0; identifiable (θ, ζ))
Next, we study the properties of the penalized estimation procedure given that
the true β is not 0. First, we show that the penalized estimator is consistent if
assumptions 1 and 3 (presented in the Appendix) are hold. Note that assumption
3 for the likelihood function does not put constraints on the differentiability of the
likelihood function with respect to the parameter ζ. It is because the differentia-
bility with respect to ζ might not be hold in general. For examples, if we consider
the parametric model of the example 3 in [Davtes, 1977], let Y = (y1, ..., yn) repre-
sent a random n independently and identically distributed sample from the density
f(y; β, ζ) = (1− β)e−y + βζe−ζy, where 1 < ζ <∞. The likelihood function is differ-
entiable with respect to parameter ζ. When β = 0, it renders ζ to be unidentifiable.
However, for the linear model with change point in [Bacon and Watts, 1971],
Y = (γ0 + γ1X) + β(X − ζ)I(X > ζ) + , (4.2.2)
where X is covariate,  is random error following standard normal distribution, and
I(X > ζ) is an indicator variable: I(X > ζ) = 1 if X > ζ. The likelihood function
for this model is not differentiable with respect to ζ. Similarly, if β = 0, it renders ζ
to be unidentifiable.
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We first establish consistency property of the penalized estimator (θ˜(n), ζ˜(n)) with-
out assuming the differentiability of likelihood function with respect to ζ in the The-
orem 2.
Theorem 2. Given β 6= 0, and under the assumptions 1 and 3 (the assumption 3 is
from Wald [1949] presented in the Appendix), then P (limn→∞(θ˜(n), ζ˜(n)) = (θ, ζ)) =
1, where (θ, ζ) ∈ Θ1 × Ξ1. (The proof of Theorem 2 can be found in the Appendix.)
The argument to establish the property of the asymptotic normality of the penal-
ized estimator depends on the differentiability of the likelihood function with respect
to ζ. If Assumptions 1 3, and 4 (presented in the Appendix): the likelihood func-
tion is second order differentiable with respect to ζ, holds, Theorem 3 gives that the
asymptotic normality of the penalized estimator (θ˜(n), ζ˜(n)).
Theorem 3. Under the assumptions 1, 2, and 4 for likelihood functions and assume
(θ, ζ) ∈ Θ1 × Ξ1, if λnn−1/2 → 0, then
√
n((θ˜(n), ζ˜(n)) − (θ, ζ)) →d N(0, I(θ, ζ)−1),
where I(θ, ζ) is the fisher information matrix. The proof of Theorem 3 is a direct
adaption from Fan and Li [2001]; therefore, it is omitted.
However, if the Assumption 4 does not hold, it is required to address this issue
specifically to prove the asymptotic normality of the penalized estimator. In this pa-
per, we take the one change point model as an example, and establish the asymptotic
normality of the penalized estimator for this particular model, where the likelihood
function is not differentiable with respect to ζ.
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Asymptotic normality of the penalized estimator for the one change
point model
Consider (y1, ..., yn) to represent a independent n samples, where yi = (zi, wi),
zi is a random vectors, and wi is a 1-dimension random variable associated to the
change point ζ. Specifically, the sample points yi are assumed to be independently
drawn from the parametric model:
f1(yi; γ) for wi ≤ ζ; f2(yi; γ, β) for wi > ζ, (4.2.3)
This model describes that the density function f of each sample i depends on the
value of wi with respect to the thresholding parameter ζ. Furthermore, to adapt a
similar set-up from [He and Severini, 2010], the n sample can be rearranged to an
order as drawn from the one change point model by 0 < n1 < n based on wi and ζ,
f1(yi; γ) for 1 ≤ i ≤ n1, where wi ≤ ζ (4.2.4)
f2(yi; γ, β) for n1 + 1 ≤ i ≤ n, where wi > ζ. (4.2.5)
Clearly, both n1 and ζ are change point parameters. An known parameter ζ and
the observed values of wi for each sample can transform to an known parameter n1.
The parameter γ, a vector with s − 1 elements is unknown common parameter for
f1 and f2, and β is an one-dimensional unknown within-segment parameter for f2.
Note that if β = 0, f2(yi; γ, β = 0) is equivalent to f1(yi; γ), which renders ζ to be
unidentifiable. The corresponding log likelihood function is
l´ ≡ l(θ, ζ) =
n∑
i=1
log {I(wi ≤ ζ)f1(yi; γ) + I(wi > ζ)f2(yi; γ, β)} (4.2.6)
. (4.2.7)
Theorem 4. Given β 6= 0 and under the Assumptions 5 from [He and Severini,
2010], which are presented in the Appendix for likelihood function, if λnn
−1/2 → 0,
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then
√
n(θ˜(n) − θ)→d N(0, I(θ)−1), where θ ∈ Θ1.
Theorem 4 establishes the asymptotic normality property of the penalized esti-
mator for one change point model. The corresponding proof can be found in the
Appendix.
The following simulation section is based on the one change point model to eval-
uate the empirical performance of the penalized estimator.
4.3 Simulation studies
To evaluate the performance of the penalization estimation approach, we compare
our method to the regular maximum likelihood estimation procedure by a set of
simulated data under the non-identifiable or identifiable model scenarios. Specifically,
we consider yi = (zi, wi) following the one change point model:
zi = δ0 + wiδ1 + wiβI(wi > ζ) + i. (4.3.1)
Covariates X = (x1, ...xn) and W = (w1, ...wn) are both simulated as n i.i.d standard
normal random variables respectively. The change point ζ is set as 0, the intercept δ0
is set as 0.5, and the slope δ1 is set as 0.25. Additionally, each residual i is indepen-
dently and identically distributed random variable following normal distribution with
mean 0 and variance 0.5. We consider 16 situations involving different combinations
of sample size n and effect sizes of β: n = 50, 200, 1000, or 3000, and β = 0, 0.5, 1.0, or
2.0. The response variables z = (z1, ..., zn) are simulated accordingly based on (4.3.1).
The likelihood incorporated into the penalized estimation procedure is from one
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change point model for all 16 simulation scenario. When β = 0, which corresponds
to no change point model, the maximum likelihood estimation is based on the likeli-
hood from the model without change point or the model with one change point with
unknown change point position. On the other hand, when β 6= 0, the maximum
likelihood estimation is based on the likelihood from one change point model with
known or unknown change point position.
To estimate the position of the unknown change point, an arbitrary interval
(−2, 2) by 0.01 increment is provided for both penalized and regular maximum like-
lihood estimation procedures. In addition, an initial set of 25 tuning parameter λ is
provided for penalized estimation. Bayesian Information Criterion (BIC) is used for
the selection of tuning parameter.
Each simulation scenario consists of 1000 replications. We calculate the mean,
median, mean and median of the model based variance, empirical variance and cov-
erage probability of the true values of δ1 and β. Let PMLE denote our penalized
estimation procedure. Additionally, let MLEn, MLEc and MLEuc denote regular
maximization likelihood estimation approach for model without change point, one
change point model with known position or unknown position respectively.
The results shown in Table 1 are for the not identifiable model where β = 0.
They suggest that as sample size becomes larger, the performance of the penalized
estimator becomes similar to that of regular maximum likelihood estimation based
on model without change point.
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The results shown in Tables 2 to 4 are for the identifiable model where β 6= 0. They
suggest that as sample size and the effect size of β become larger, the performance
of the penalized estimator becomes similar to that of regular maximum likelihood
estimation based on one change point model with unknown change point position.
Table 4.1: Empirical studies of the penalized estimation procedure for model without
change point, with sample size n = (50, 200, 1000, or 3000), δ1 = 0.25 and β = 0. For
penalization estimation approach, the tuning parameter is selected to minimize BIC. We
compare the penalization estimation approach to regular maximum likelihood function
estimation for one change point model with known or unknown change point. We present
the mean of the estimates of δ1, β and ζ across 1000 simulations. In addition, we present
the mean of model-based variance estimator, and empirical variance estimator for δ1 and
β. Moreover, the coverage probabilities for δ1 and β are presented.
δ1 = 0.25 δ˜1 varm(δ˜1) vare(δ˜1) cover # sim β˜ varm(β˜) vare(β˜) ζ˜
β = 0 mean mean P β˜ = 0 mean mean mean
n = 50
MLEn 0.245 0.01019 0.0117 0.925 − − − − −
MLEuc 0.246 0.02074 0.04109 0.83 − -0.005 0.07312 0.21068 -0.304
PMLEbic 0.247 0.01047 0.01483 0.909 966 -0.002 0.05699 0.02047 -0.018
n = 200
MLEn 0.252 0.00274 0.00263 0.955 − − − − −
MLEuc 0.257 0.00779 0.02145 0.755 − -0.008 0.01716 0.06346 -0.031
PMLEbic 0.251 0.00281 0.00363 0.944 987 0 0.01708 0.00304 -0.001
n = 1000
MLEn 0.252 0.00052 0.00053 0.946 − − − − −
MLEuc 0.254 0.00163 0.00505 0.752 − -0.002 0.00352 0.01487 -0.094
PMLEbic 0.252 0.00053 0.00062 0.942 995 -0.001 0.00329 0.00027 -0.002
n = 3000
MLEn 0.25 0.00017 0.00018 0.936 − − − − −
MLEuc 0.251 0.00051 0.00147 0.769 − -0.003 0.00112 0.00444 0.042
PMLEbic 0.25 0.00017 0.00019 0.934 998 0 0.00097 3e-05 0
−: Not applicable.
MLEn: MLE with likelihood for no change point model.
MLEuc: MLE with likelihood for unknown change point position.
PMLEbic: PMLE using BIC to select tuning parameter.
varm: Model based variance estimator.
vare: Empirical variance estimator.
4.4 Real data analysis
To evaluate the performance of the penalized estimation procedure, we analyze
three data sets.
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Table 4.2: Empirical studies of the penalized estimation procedure for one change point
model, with sample size n = (50, 200, 1000, or 3000), δ1 = 0.25 and β = 0.5. For penaliza-
tion estimation approach, the tuning parameter is selected to minimize BIC. We compare
the penalization estimation approach to regular maximum likelihood function estimation
for one change point model with known or unknown change point. We present the mean of
the estimates of δ1, β and ζ across 1000 simulations. In addition, we present the mean of
model-based variance estimator, and empirical variance estimator for δ1 and β. Moreover,
the coverage probabilities for δ1 and β are presented.
δ1 = 0.25 δ˜1 varm(δ˜1) vare(δ˜1) cover # sim β˜ varm(β˜) vare(β˜) cover ζ˜
β = 0.5 mean mean P β˜ = 0 mean mean P mean
n = 50
MLEc 0.249 0.03271 0.03533 0.933 − − − − − −
MLEuc 0.244 0.02224 0.03151 0.892 − 0.505 0.0565 0.08905 0.889 -0.144
PMLEbic 0.396 0.01177 0.04144 0.396 759 0.199 0.05326 0.13256 0.198 -0.029
n = 200
MLEc 0.258 0.01001 0.01028 0.955 − − − − − −
MLEuc 0.274 0.00709 0.00956 0.868 − 0.451 0.01825 0.02231 0.912 -0.023
PMLEbic 0.353 0.00495 0.02312 0.492 467 0.294 0.01868 0.08198 0.518 0.014
n = 1000
MLEc 0.253 0.00185 0.00191 0.94 − 0.496 0.00528 0.00551 0.948 −
MLEuc 0.272 0.00158 0.00223 0.859 − 0.457 0.00419 0.00642 0.812 0.007
PMLEbic 0.272 0.00158 0.00223 0.859 0 0.457 0.00419 0.00642 0.812 0.007
n = 3000
MLEc 0.249 0.00061 0.00063 0.942 − 0.502 0.00185 0.00185 0.954 −
MLEuc 0.26 0.00057 0.00081 0.876 − 0.48 0.00165 0.00249 0.858 -0.002
PMLEbic 0.26 0.00057 0.00081 0.876 0 0.48 0.00165 0.00249 0.858 -0.002
−: Not applicable.
MLEc: MLE with likelihood for known change point position.
MLEuc: MLE with likelihood for unknown change point position.
PMLEbic: PMLE using BIC to select tuning parameter.
varm: Model based variance estimator.
vare: Empirical variance estimator.
4.4.1 Stagnant band height data example
The first dataset we consider is from [Bacon and Watts, 1971], which were origi-
nally obtained from the Ph.D. thesis of R. A. Cook. The dataset is from the experi-
ments to study the relationship between the stagnant-band-height and the controlled
various flow rate of water down an inclined channel using different surfactants. The
response variable is the logarithm of stagnant surface layer height in centimeters and
the predictor variable is the logarithm of the water flow rate in grams per centimeter
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Table 4.3: Empirical studies of the penalized estimation procedure for one change point
model, with sample size n = (50, 200, 1000, or 3000), δ1 = 0.25 and β = 1.0. For penaliza-
tion estimation approach, the tuning parameter is selected to minimize BIC. We compare
the penalization estimation approach to regular maximum likelihood function estimation
for one change point model with known or unknown change point. We present the mean of
the estimates of δ1, β and ζ across 1000 simulations. In addition, we present the mean of
model-based variance estimator, and empirical variance estimator for δ1 and β. Moreover,
the coverage probabilities for δ1 and β are presented.
δ1 = 0.25 δ˜1 varm(δ˜1) vare(δ˜1) cover # sim β˜ varm(β˜) vare(β˜) cover ζ˜
β = 1.0 mean mean P β˜ = 0 mean mean P mean
n = 50
MLEc 0.246 0.03756 0.03958 0.93 − − − − − −
MLEuc 0.28 0.02729 0.03544 0.9 − 0.939 0.07679 0.09672 0.905 0.009
PMLEbic 0.374 0.02195 0.07847 0.63 320 0.738 0.07501 0.29628 0.651 0.016
n = 200
MLEc 0.254 0.00916 0.00863 0.955 − − − − − −
MLEuc 0.301 0.00737 0.01068 0.843 − 0.903 0.02148 0.03362 0.802 -0.026
PMLEbic 0.301 0.00736 0.01111 0.843 3 0.902 0.0215 0.03521 0.802 -0.023
n = 1000
MLEc 0.25 0.00178 0.00172 0.952 − − − − − −
MLEuc 0.267 0.00167 0.00203 0.894 − 0.965 0.00498 0.00631 0.866 -0.007
PMLEbic 0.267 0.00167 0.00203 0.894 0 0.965 0.00498 0.00631 0.866 -0.007
n = 3000
MLEc 0.249 0.00065 0.00064 0.955 − 1.002 0.00183 0.00172 0.959 −
MLEuc 0.257 0.00063 0.00072 0.922 − 0.985 0.00176 0.00208 0.903 0
PMLEbic 0.257 0.00063 0.00072 0.922 0 0.985 0.00176 0.00208 0.903 0
−: Not applicable.
MLEc: MLE with likelihood for known change point position.
MLEuc: MLE with likelihood for unknown change point position.
PMLEbic: PMLE using BIC to select tuning parameter.
varm: Model based variance estimator.
vare: Empirical variance estimator.
per second.
We fit a linear regression model to this data: zi = δ0 + w
′
iδ1 + wiβI(wi > ζ) + i,
where zi and wi stand for the response and predictor variables respectively. The
obtained model is E(zi) = 0.46− 0.46wi − 0.53wiI(wi > 0.29); the left plot in figure
1 shows the sample points with the fitted line.
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Table 4.4: Empirical studies of the penalized estimation procedure for one change point
model, with sample size n = (50, 200, 1000, or 3000), δ1 = 0.25 and β = 2.0. For penaliza-
tion estimation approach, the tuning parameter is selected to minimize BIC. We compare
the penalization estimation approach to regular maximum likelihood function estimation
for one change point model with known or unknown change point. We present the mean of
the estimates of δ1, β and ζ across 1000 simulations. In addition, we present the mean of
model-based variance estimator, and empirical variance estimator for δ1 and β. Moreover,
the coverage probabilities for δ1 and β are presented.
δ1 = 0.25 δ˜1 varm(δ˜1) vare(δ˜1) cover # sim β˜ varm(β˜) vare(β˜) cover ζ˜
β = 2.0 mean mean P β˜ = 0 mean mean P mean
n = 50
MLEc 0.257 0.03159 0.03223 0.939 − − − − − −
MLEuc 0.323 0.02612 0.03595 0.865 − 1.839 0.07382 0.11555 0.795 -0.058
PMLEbic 0.323 0.02612 0.03595 0.865 0 1.839 0.07382 0.11555 0.795 -0.058
n = 200
MLEc 0.249 0.01041 0.01049 0.95 − 2.005 0.03322 0.03494 0.94 −
MLEuc 0.292 0.00947 0.0126 0.889 − 1.912 0.02919 0.04387 0.845 0.003
PMLEbic 0.292 0.00947 0.0126 0.889 0 1.912 0.02919 0.04387 0.845 0.003
n = 1000
MLEc 0.25 0.00185 0.00184 0.956 − 2.002 0.00552 0.00544 0.952 −
MLEuc 0.263 0.0018 0.0021 0.922 − 1.975 0.00534 0.0064 0.911 0.002
PMLEbic 0.263 0.0018 0.0021 0.922 0 1.975 0.00534 0.0064 0.911 0.002
n = 3000
MLEc 0.251 0.00065 0.00064 0.95 − 1.998 0.00182 0.0018 0.953 −
MLEuc 0.258 0.00064 0.00066 0.936 − 1.985 0.0018 0.00194 0.921 -0.003
PMLEbic 0.258 0.00064 0.00066 0.936 0 1.985 0.0018 0.00194 0.921 -0.003
−: Not applicable.
MLEc: MLE with likelihood for known change point position.
MLEuc: MLE with likelihood for unknown change point position.
PMLEbic: PMLE using BIC to select tuning parameter.
varm: Model based variance estimator.
vare: Empirical variance estimator.
4.4.2 Metabolic pathways data example
The second data is from [Julious, 2001], which aims to study the switch of
metabolic pathways in persons during physical exercise. To examine whether the
metabolic pathways change from aerobic to anaerobic when people produce energy
during exercise, volume of carbon dioxide exhaled and volume of oxygen inhaled are
measured for outcome and predictor variables. The measurements are taken on a sin-
gle person per every 30 seconds up to a maximum of 17.5 minutes. A linear regression
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model with a change point between two segmented lines was fitted to this data, where
the change point, if exists, represents the switch between metabolic pathways. As
shown in [Julious, 2001], the best fitting two segmented lines model is
zi = 0.076 + 0.042wi (wi ≤ 39.46); zi = −1.659 + 0.086wi (39.46 < wi).
We also fit a linear regression model with two segmented lines to this data, and the
obtained model is the same as above. The right plot in figure 1 shows the sample
points with the fitted line.
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Figure 4.1: The left plot is for the stagnant band height data from [Bacon and Watts,
1971] with the fitted line by the penalized estimation procedure. The right plot is
for the metabolic pathways data from [Bacon and Watts, 1971] with the fitted line
by the penalized estimation procedure.
4.4.3 Drug sensitivity data example
In a panel of several hundred human cancer cell lines, [Garnett et al., 2012] mea-
sured the sensitivities of drugs and genomic factors. We have applied our method to
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the data of drug 17-AAG to identify the change point linear relationship between the
response variable, the half-maximal inhibitory concentration (IC50), i.e., the amount
of drugs to kill 50% of the cancer cells on the log scale, and the logarithm of gene
expression. Drug 17-AAG is an HSP90 inhibitor, and has shown its significant anti-
tumor activity for various types of cancer in clinical studies Usmani et al. [2009].
Figure 2 presents the relationship between the log(IC50) of 17-AAG and two gene
expression variables NQO1 and ZNF273 on the log scale. The gene expression of
NQO1 is upregulated in livers of hepatocarcinoma patients, and has been studied its
role in the cancer development Joseph et al. [1994]. Moreover, it has been suggested
a promising therapeutic target for pancreatic cancer Ough et al. [2005]. ZNF273 is
a member of the zinc-finger protein family and involved in transcriptional regulation
(NCBI Gene ID: 10793). The analysis results by our method suggest that the re-
lationship between log(IC50) of 17-AAG and NQO1 gene expression on log scale is
simple linear trend while a change-point linear model fits better for the relationship
between log(IC50) of 17-AAG and ZNF273 gene expression on log scale.
4.5 Additional conditions and asymptotic results
Following [Andrews and Ploberger, 1995],the likelihood function L(n)(θ, ζ) is as-
sumed to satisfy the following assumption 2. The Assumption 2.3 is the simplified
version assuming for nontrending data.
Assumption 2.
2.1 L(n)(θ, ζ) does not depend on ζ for all θ ∈ Θ0.
2.2 l (n)(θ; ζ) is twice differentiable with respect to θ for all (θ, ζ) ∈ Θ0 × Ξ.
2.3 supζ∈Ξ, θ∈Θ0 | − n−1 l¨ (n)(θ; ζ) − I(θ; ζ)| →p 0, where I(θ; ζ) is the asymptotic
information matrix for θ ∈ Θ0 at a given ζ ∈ Ξ, which depends on both θ and
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Figure 4.2: The left plot shows the fitted line for log(IC50) of 17-AAG and the gene
expression of NQO1 on log scale by the penalized estimation procedure. The right
plot is for log(IC50) of 17-AAG and the gene expression of ZNF273 on log scale.
ζ, and is assumed to be positive definite.
2.4 For each θ ∈ Θ0, n−1/2 l˙ (n)(θ; ·) → G(θ, ·), as processes indexed by ζ ∈ Ξ for
some mean zero Rs-valued Gaussian stochastic process {G(θ, ζ) : ζ ∈ Ξ} that
has E[G(θ, ζ)G(θ, ζ)T] = I(θ; ζ) ∀ζ ∈ Ξ and has continuous sample path as
functions of ζ for a fixed θ with probability 1. Moreover, we assumed that
supζ∈Ξ n
−1/2 l˙ (n)(θ; ζ) = Op(1)
2.5 For all j, k, l = 1, ...s, and all θ in some neighborhood of θ ∈ Θ0,
sup
ζ∈Ξ
| ∂
3
∂θj∂θk∂θl
log f(yi; θ, ζ)|
are dominated by integrable functions.
87
Assumption 3. Following [Wald, 1949], let F (y; (θ, ζ)) denote the cumula-
tive distribution function of yi; i.e., F (y; (θ, ζ)) = P (yi < y). Additionally, let
f(y; (θ, ζ), ρ) be the supremum of f(y; (θ′, ζ ′)) with respect to (θ′, ζ ′) when ‖(θ, ζ)−
(θ′, ζ ′)‖ ≤ ρ. For any positive r, let pi(y, r) be the supremum of f(y; (θ′, ζ ′)) with re-
spect to (θ′, ζ ′) when ‖(θ, ζ)‖ ≥ r. In addition, let f ∗(y; (θ, ζ), ρ) = f(y; (θ, ζ), ρ) when
f(y; (θ, ζ), ρ) > 1, and = 1 otherwise. Also, let pi∗(y, r) = pi(y, r) when pi(y, r) > 1,
and = 1 otherwise. (The following assumptions 3.1 to 3.4 are from [Wald, 1949].)
3.1 F (y; (θ, ζ)) is either discrete or absolutely continuous for all (θ, ζ) ∈ Θ1 × Ξ1.
3.2 For sufficiently small ρ and large r, the expected values∫∞
−∞ log f
∗(y; (θ, ζ), ρ)dF (y; (θ1, ζ1)) and
∫∞
−∞ log pi
∗(y, r)dF (y; (θ1, ζ1)) are finite,
where (θ1, ζ1) ∈ Θ1 × Ξ1 denote the true parameter.
3.3 If (θj, ζj) is a parameter point different from the true parameter (θ, ζ) ∈ Θ1×Ξ1,
then F (y; (θj, ζj)) 6= F (y; (θ, ζ)) for at least one value of y.
3.4 For (θ, ζ) ∈ Θ1 × Ξ1,
∫∞
−∞ | log f(y; (θ, ζ))|dF (y; (θ, ζ)) <∞.
3.5 λnL(n)(θ1; ζ1)−1 → 0.
Assumption 4
l (n)(θ, ζ) is second order differentiable with respect to ζ.
Proof of Theorem 1
The proof consists of three parts. The first part is to show that there exists a local
maximizer (θ˜(n), ζ˜(n)) of Q(n)(θ, ζ) satisfying ‖θ˜(n) − θ0‖ = Op(n−1/2), and the second
part is to prove P (β˜(n) = 0)→ 1 as n→∞. The final part is to show the asymptotic
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normality of γ˜(n).
First, we show that there exists a local maximizer (θ˜(n), ζ˜(n)) ofQ(n)(θ, ζ) satisfying
‖θ˜(n) − θ0‖ = Op(n−1/2). Letting θ˜(n) = θ0 + n−1/2u for a fixed u = (u1, u2)T, where
u1 corresponds to β, and u2 corresponds to γ. In particular, for any  > 0, there
exists a large enough constant C such that
P
{
sup
ζ∈Ξ
[
sup
‖u‖=C
Q(n)(θ0 + n
−1/2u; ζ)−Q(n)(θ0; ζ)
]
< 0
}
≥ 1− , (4.5.1)
where Q(n)(θ0; ζ) = L(n)(θ0)− λn√n |ζ|.
The first step is to consider at a fixed ζ, we want to show that there exists a large
enough constant Cζ for any  > 0 such that
P
{
sup
‖u‖=Cζ
[
Q(n)(θ0 + n
−1/2u; ζ)−Q(n)(θ0; ζ)
]
< 0
}
≥ 1− . (4.5.2)
Define
D(n)(u; ζ) = Q(n)(θ0 + n
−1/2u; ζ)−Q(n)(θ0; ζ).
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By Taylor expansion of L(n)(θ0 + n−1/2u; ζ) at θ0, we can obtain
D(n)(u; ζ) = n−1/2 ˙ln(θ0; ζ)Tu
−− 1
2n
uT
{
l¨n(θ0; ζ)
}
u
+(n−3/2/6)
s∑
j,k,l=1
...
ln(θˇ; ζ)ujukul
+λnn
−1/2wˆnn1/2
{|β0| − |β0 + n−1/2u1|}
+
λn√
n
{
I(β0 = 0)− I(β0 + n−1/2u1 = 0)
} |ζ|
= n−1/2 ˙ln(θ0; ζ)Tu
−− 1
2n
uT
{
l¨n(θ0; ζ)
}
u
+(n−3/2/6)
s∑
j,k,l=1
...
ln(θˇ; ζ)ujukul
+λnn
−1/2wˆn {−|u1|}
+
λn√
n
{
1− I(β0 + n−1/2u1 = 0)
} |ζ|
≡ Γ(n)1 (ζ)− Γ(n)2 (ζ) + Γ(n)3 (ζ) + Γ(n)4 + Γ(n)5 (ζ),
for some θˇ between θ0 and θ0 + n
−1/2u.
By the assumptions 2.3 and 2.4, Γ
(n)
1 = Op(1), Γ
(n)
2 → I(θ0; ζ), the asymptotic
information matrix. Both Γ
(n)
3 and Γ
(n)
5 converge to zero by assumption. If u1 6= 0,
then Γ
(n)
4 = λnn
(2ατ−1)/2|nαβˆ∗|−τ |u1| → −∞ by nαβˆ∗ = Op(1) and λnn(2ατ−1)/2 →∞.
Since the rest terms are all finite, D(n)(u; ζ) → −∞ and (4.5.2) holds for any ζ.
On the other hand, if u1 = 0, then Γ
(n)
4 = 0. Since Γ
(n)
22 is positive, by choosing a
sufficiently large Cζ to have Γ
(n)
1 dominated by the rest terms, (4.5.2) holds.
To establish equation (4.5.1), note that if u1 6= 0, since Γ(n)4 → −∞ regardless of
the value of ζ, equation (4.5.1) is satisfied automatically. Therefore, we only need
consider the situation where u1 = 0 so that Γ
(n)
4 = 0, and the event we are interested
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in is
sup
ζ∈Ξ
sup
‖u‖=Cζ
[
Q(n)(θ0 + u; ζ)−Q(n)(θ0; ζ)
]
= sup
‖u‖=C
sup
ζ∈Ξ
[
D(n)(u; ζ)
]
.
Note that
sup
ζ∈Ξ
D(n)(u; ζ) = sup
ζ∈Ξ
{
Γ
(n)
1 (ζ)− Γ(n)2 (ζ) + Γ(n)3 (ζ) + Γ(n)5 (ζ)
}
≤ sup
ζ∈Ξ
Γ
(n)
1 (ζ) + sup
ζ∈Ξ
[−Γ(n)2 (ζ)] + sup
ζ∈Ξ
Γ
(n)
3 (ζ) + sup
ζ∈Ξ
Γ
(n)
5 (ζ)
Similar to the above argument, both supζ∈Ξ Γ
(n)
3 (ζ) and supζ∈Ξ Γ
(n)
5 (ζ) converges to 0.
By assumptions 2.3 and 2.4, supζ∈Ξ Γ
(n)
1 (ζ) is Op(1), and supζ∈Ξ[−Γ(n)22 (ζ)] is negative.
Taking a large enough C so that supζ∈Ξ[−Γ(n)22 (ζ)] dominates the rest of terms; then
sup
‖u‖=C
sup
ζ∈Ξ
D(n)(u; ζ) < 0.
Therefore, for any  > 0, there exists some constant C such that equation 4.5.1 holds.
For the second part, consider the event
{
β˜(n) 6= 0
}
. By the Karush-Kuhn-Tunker
optimality conditions, we have
n∑
i=1
∂
∂β
log f(yi;X, θ˜
(n), ζ˜(n)) = λnwˆnsgn(β˜
(n)).
Therefore, P (β˜(n) 6= 0) ≤ P
{∑n
i=1
∂
∂β
log f(yi;X, θ˜
(n), ζ˜(n)) = λnwˆnsgn(β˜
(n))
}
. To
study the event
{
n−1/2 ∂
∂β
log f(yi;X, θ˜
(n), ζ˜(n)) = n−1/2λnwˆnsgn(β˜(n))
}
, by Taylor ex-
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pansion on the left-had side,
n−1/2
n∑
i=1
∂
∂β
log f(yi;X, θ˜
(n), ζ˜(n))
= n−1/2
n∑
i=1
∂
∂β
log f(yi; θ0, ζ˜
(n))
+ n−1
n∑
i=1
∂2
∂β2
log f(yi;X, θ0, ζ˜
(n))n1/2(θ˜(n) − θ0)(1 + op(1))
≡ U (n)1 + U (n)2 .
Both U
(n)
1 and U
(n)
2 are Op(1) by assumptions 2.3 and 2.4, and (θ˜
(n)−θ0) = Op(n−1/2)
as shown in the first part of the proof. On the right-hand side, n−1/2λnwˆnsgn(β˜(n))) =
λnn
(2ατ−1)/2|nαβˆ∗|−τ →∞; as a consequence, P (β˜(n) 6= 0)→ 0.
Finally, to show the normality of γ˜(n), since the likelihood L(n)(θ, ζ) is unidenti-
fiable when θ = θ0. We cannot use the same approach to establish the normality of
the nonzero estimator γ˜(n) as [Fan and Li, 2001]. They conduct the partial Taylor
expansion with respect to γ of ∂Q
(n)(θ,ζ)
∂γ
|(θ,ζ)=((0,γ˜),ζ˜) = 0 as follows.
0 =
1√
n
∂L(n)(θ, ζ)
∂γ
|θ=θ0,ζ=ζ0
+
1
n
[
n∑
i=1
∂2
∂γ2
log f(yi; θ, ζ)|θ=θ0,ζ=ζ0 + op(n)
]
√
n(γ˜(n) − γ0).
Clearly, due to the unidentifiability issue, when θ = θ0, there is no existence of ζ0.
Therefore, the limits of 1√
n
∂L(n)(θ,ζ)
∂γ
|θ=θ0,ζ=ζ0 and 1n
∑n
i=1
∂2
∂γ2
log f(yi; θ, ζ)|θ=θ0,ζ=ζ0 do
not exist. Only the point-wise limits of 1√
n
∂L(n)(θ,ζ)
∂γ
|θ=θ0 and 1n
∑n
i=1
∂2
∂γ2
log f(yi; θ, ζ)|θ=θ0
at any fixed point of ζ ∈ Ξ exist.
Since we already show that there exists a large enough N , for any n ≥ N , β˜(n) = 0,
it can be observed that Q(n)(β˜(n) = 0, γ˜(n); ζ˜(n)) = l (n)(γ˜(n)). Therefore, l (n)(γ˜(n)) is
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no longer involving with β and ζ, and equivalent to l
(n)
0 (γ˜
(n)). At this point, γ˜(n)
essentially maximizes l
(n)
0 (γ).
By Taylor expansion of
∑n
i=1
∂
∂γ
log f0(yi; γ˜
(n)) around γ0,
0 =
n∑
i=1
∂
∂γ
log f0(yi; γ0) +
n∑
i=1
∂2
∂γ2
log f0(yi; γ0)(γ˜
(n) − γ0)(1 + op(n)),
After rearrangement
n−1/2
n∑
i=1
∂
∂γ
log f0(yi; γ0) = − 1
n
n∑
i=1
∂2
∂γ2
log f0(yi; γ0)
√
n(γ˜(n) − γ0) + op(1).
Therefore,
√
n(γ˜(n)−γ0)→d N(0, I(γ0)−1), where I(γ0) is the Fisher information ma-
trix corresponding to L(n)0 (γ0)
Proof of Theorem 2
To show P (limn→∞(θ˜(n), ζ˜(n)) = (θ1, ζ1)) = 1, we follow the strategy of proof for
the Theorem 2 in [Wald, 1949].
Since (θ˜, ζ˜) satisfies
Q(n)(θ˜, ζ˜)
Q(n)(θ1, ζ1)
≥ 1 > 0, for all n and for all y1, ..., yn.
It is sufficient to show that for any  > 0 the probability is one that all limit
points (θ˜, ζ˜) of (θ˜(n), ζ˜(n)) satisfying ‖(θ˜, ζ˜)− (θ1, ζ1)‖ ≤ .
Consider the event that there exists a limit point (θ˘, ζ˘) such that ‖(θ˘, ζ˘)−(θ1, ζ1)‖ >
. This implies that sup‖(θ,ζ)−(θ1,ζ1)‖>Q
(n)(θ, ζ) ≥ Q(n)(θ˘, ζ˘) so that
sup‖(θ,ζ)−(θ1,ζ1)‖>Q
(n)(θ, ζ)
Q(n)(θ1; ζ1)
≥ c > 0
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for infinitely many n. Therefore, it is sufficient to show that this is an event with
probability 0.
To establish this, we will show that
P
{
lim
n→∞
sup(θ,ζ)∈ωQ
(n)(θ; ζ)
Q(n)(θ1; ζ1)
= 0
}
= 1, (4.5.3)
where ω be any closed subset of the parameter space Θ× Ξ which does not contain
the true parameter point (θ1, ζ1).
Clearly, sup(θ,ζ)∈ωQ
(n)(θ; ζ) ≤ sup(θ,ζ)∈ω L(n)(θ; ζ). Therefore, equation (4.5.3) is
proved if we can show that
P
{
lim
n→∞
sup(θ,ζ)∈ω L(n)(θ; ζ)
Q(n)(θ1; ζ1)
= 0
}
= 1, (4.5.4)
Based on the assumption 3 and the Theorem 1 in [Wald, 1949], the likelihood
part of Q(n)(θ; ζ) satisfies
P
{
lim
n→∞
sup(θ,ζ)∈ω L(n)(θ; ζ)
L(n)(θ1; ζ1) = 0
}
= P
{
lim
n→∞
log
{
sup(θ,ζ)∈ω L(n)(θ; ζ)
L(n)(θ1; ζ1)
}
= −∞
}
= 1.
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Therefore,
P
{
sup(θ,ζ)∈ω L(n)(θ; ζ)
Q(n)(θ1; ζ1)
= 0
}
= P
{
sup(θ,ζ)∈ω L(n)(θ; ζ)
L(n)(θ1; ζ1)[1− (λnwˆn|β1|+ λn√nI(β1 = 0)|ζ1|)/L(n)(θ1; ζ1)]
= 0
}
= P
{
lim
n→∞
{
log
[
sup(θ,ζ)∈ω L(n)(θ; ζ)
L(n)(θ1; ζ1)
]
+ log
[
1
(1− δn(θ1, ζ1))
]}
= −∞
}
≈ P
{
lim
n→∞
log
{
sup(θ,ζ)∈ω L(n)(θ; ζ)
L(n)(θ1; ζ1)
}
= −∞
}
= 1 since
1− δn(θ1, ζ1)
= 1−
{[
λnwˆn|β1|+ λn√
n
I(β1 = 0)|ζ1|
]
/L(n)(θ1; ζ1)
}
= 1− {λnwˆn|β1|/L(n)(θ1; ζ1)}→ 1
by the assumptions 1.2 and 3.5, wˆn → |cβ|−τ and λn/L(n)(θ1; ζ1)→ 0.
Therefore, with probability 1, limn→∞(θ˜(n), ζ˜(n)) = (θ1, ζ1).
Notations
Following [He and Severini, 2010], let Λ1 = n1/n be the true percentage of sample with
the observed wi less than or equal to ζ for a sample with size n, and Λ
0
1 be the constant
fraction value as n→∞. Additionally, let n˜(n)1 denote the estimate of the percentage
of sample with the observed wi less than or equal to ζ, n˜
(n)
1 =
∑n
i=1 I(wi ≤ ζ˜(n)). The
expected information matrix is given by I(θ) = E[− ∂2
∂θ2
l´ ], where θ ∈ Θ1.
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Assumption 5
5.1 f1(yi; γ) 6= f2(yi; γ, β) on a set of non-zero measure given β 6= 0.
5.2 l´ is third-order continuously differentiable with respect to θ.
5.3 The expectations of the first and second order derivatives of l´ with respect to
θ exist for θ in its parameter space.
Proof of Theorem 4
The penalized likelihood function is differentiable at β 6= 0,
∂
∂θ
Q(n)(θ, ζ) =
∂
∂θ
ln(θ, ζ)− λnwˆnsgn(β).
Since (θ˜(n), ζ˜(n)) maximizes Q(n)(θ; ζ),
0 =
∂
∂θ
Q(n)(θ˜(n), ζ˜(n)) =
∂
∂θ
ln(θ˜
(n), ζ˜(n))− λnwˆnsgn(β˜(n))
=
∂
∂θ
ln(θ˜
(n), n˜
(n)
1 )− λnwˆnsgn(β˜(n)).
Then expand ∂
∂θ
ln(θ˜
(n), n˜
(n)
1 ) around
∂
∂θ
ln(θ, n˜
(n)
1 ),
√
n(θ˜(n) − θ) =
[
− 1
n
∂2
∂θ2
ln(θ, n˜
(n)
1 ) + op(1)
]−1
1√
n
[
∂
∂θ
ln(θ, n˜
(n)
1 )− λnwˆnsgn(β˜(n))
]
.
Since n−1/2λnwˆnsgn(β˜(n))→ 0, only 1√n ∂∂θ ln(θ, n˜(n)1 ) plays a critical role in determin-
ing the limiting distribution of
√
n(θ˜(n)−θ). This makes the proof for√n(θ˜(n)−θ)→d
N(0, I(θ)−1) be a special case of Theorem 2.2 and 2.3 in [He and Severini, 2010].
First, we study the behavior of 1√
n
∂
∂θ
ln(θ, n˜
(n)
1 ). Consider
1√
n
[
∂
∂θ
ln(θ, n˜
(n)
1 )−
∂
∂θ
ln(θ, n1)
]
+
1√
n
∂
∂θ
ln(θ, n1),
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and study the limiting behavior of 1√
n
[
∂
∂θ
ln(θ, n˜
(n)
1 )− ∂∂θ ln(θ, n1)
]
:
1√
n
[
∂
∂θ
ln(θ, n˜
(n)
1 )−
∂
∂θ
ln(θ, n1)
]
=
1√
n
I(n˜(n)1 ≥ n1)
n˜(n)1∑
i=1
∂
∂θ
log f1(yi; γ) +
n∑
i=n˜
(n)
1 +1
∂
∂θ
log f2(yi; γ, β)


=
1√
n
I(n˜(n)1 ≥ n1)
n˜
(n)
1∑
i=n1+1
[
∂
∂θ
log f1(yi; γ)− ∂
∂θ
log f2(yi; γ, β)
]
+
I(n˜
(n)
1 < n1)
n1−1∑
i=n˜
(n)
1 +1
[
− ∂
∂θ
log f1(yi; γ) +
∂
∂θ
log f2(yi; γ, β)
]
By the consistency of ζ˜(n) in the Theorem 2 and the Theorem 2.2 in [He and
Severini, 2010], 1√
n
[
∂
∂θ
ln(θ, n˜
(n)
1 )− ∂∂θ ln(θ, n1)
]
→ 0. Using similar argument, it can
be shown that − 1
n
∂2
∂θ2
ln(θ, n˜
(n)
1 ) → I¯(θ) as n → ∞. Furthermore, since ∂∂θ l0(θ) →d
N(0, I¯(θ)),
√
n(θ˜(n) − θ)→d N(0, I(θ)−1), where θ ∈ Θ1.
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CHAPTER 5: Conclusion
To summarize, the first paper investigates the applicability of the penalty func-
tions in challenging high dimensional settings such as genomic studies. We conducted
a theoretical analysis on the roles of tuning parameters with respect to the dimension
of the problem and minimum effect size. The results suggest that the derivatives
of the penalty function around 0 and the minimum effect size are two important
quantities to be considered. A good performance of the penalized estimation requires
that these two quantities be asymptotically different. Among the four penalties dis-
cussed in this paper, tuning one regularization parameter is sufficient to exploit the
advantages of SCAD. In contrast, MCP, SICA and Log’s performances can be signif-
icantly improved if two instead of one (λ) regularization parameter is tuned. These
theoretical conclusions are well supported in our empirical studies. In our simula-
tions, we also observe that a penalized estimation using SICA or Log appears to be
computationally more efficient than using MCP. The good performance of tuning
two regularization parameters comes with the cost of added computational time. In
real data analysis, one needs to judge the difficulty of the penalization problem in
terms of effect size and dimensionality in order to choose whether one or two regu-
larization parameters are needed, and the theoretical results of this paper can guide
such choices. These theoretical results are based on the sufficient conditions of the
weak oracle property, and thus they could be refined if the sufficient and necessary
conditions of the weak oracle property are available, though deriving such conditions
itself is a very challenging task.
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Based on the results in the first paper, we designed a new method, BipLog, for the
bi-level selection of genomic features related to cancer drug sensitivity. BipLog can
select the covariates shared by a group of response variables as well as the covariates
that are associated with one or a few of the response variables. The application of Bi-
pLog to real-data analysis reveals many interesting results. This is partly due to the
strong effect size in the data. In contrast to genome-wide association studies where a
genetic variant may explain only a few percentage of the variation in the trait of in-
terest, the genomic features measured in tumor tissues have a strong influence on the
cancer progression and its response to drug treatment. This makes cancer genomic
studies one of a few areas where statistical methods can make a major contribution
in the near future to disease prevention and treatment.
For the third paper, we constructed an estimation procedure for the models where
a certain parameter values such as β = 0 will cause an identifiability issue. We uti-
lize the idea of penalization estimation procedure and apply adaptive Lasso penalty.
In addition, we established the asymptotic results for our penalized estimation pro-
cedure, and evaluated its performances in the simulation study and real data analysis.
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